<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html xmlns:o="urn:schemas-microsoft-com:office:office" __expr-val-dir="ltr" dir="ltr"><head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
<meta name="GENERATOR" content="Microsoft SharePoint"/><meta name="progid" content="SharePoint.WebPartPage.Document"/><meta http-equiv="Expires" content="0"/><meta name="ROBOTS" content="NOHTMLINDEX"/><title>
	Proposed Revision | APA DSM-5
</title><link rel="stylesheet" type="text/css" href="../../_layouts/1033/styles/HtmlEditorCustomStyles.css"/>
<link rel="stylesheet" type="text/css" href="../../_layouts/1033/styles/HtmlEditorTableFormats.css"/>
<link rel="stylesheet" type="text/css" href="../../_layouts/1033/styles/core.css"/>
<link rel="stylesheet" type="text/css" href="../../Style Library/DSM_Css/DSM.css"/>
<script type="text/javascript" language="javascript" src="../../_layouts/1033/init.js"></script>
<script type="text/javascript" language="javascript" src="../../_layouts/1033/core.js" defer></script>
<script type="text/javascript" language="javascript" src="../../_layouts/1033/non_ie.js"></script>
<link type="text/xml" rel="alternate" href="http://www.dsm5.org/ProposedRevisions/_vti_bin/spsdisco.aspx"/>
	<style type="text/css">
		#DSM_MainContent {
			background-color: transparent;
			padding: 0px;
		}			
	</style>
<!--[if gte mso 9]><xml>
<o:CustomDocumentProperties>
<o:PublishingContactPicture msdt:dt="string">, </o:PublishingContactPicture></o:CustomDocumentProperties></xml><![endif]-->
<script type="text/javascript" src="../../_layouts/Emagination.jQuery/jquery-1.3.2.min.js"></script>
<script type="text/javascript" src="../../_layouts/Emagination.jQuery/jquery.easing.1.3.js"></script>
<script type="text/javascript" src="../../_layouts/Emagination.jQuery.SPServices/jquery.SPServices-0.5.7.js"></script>
<script type="text/javascript" src="../../_layouts/Emagination.jQuery.SPServices/jquery.SPServices-0.5.7.min.js"></script><script language="javascript" src="../../Style Library/DSM_js/RevisionTabs.js" type="text/javascript"></script><script language="javascript" src="../../Style Library/DSM_js/search.js" type="text/javascript"></script><style type="text/css">
	.zz1_TopNavigationMenu_0 { background-color:white;visibility:hidden;display:none;position:absolute;left:0px;top:0px; }
	.zz1_TopNavigationMenu_1 { text-decoration:none; }
	.zz1_TopNavigationMenu_2 {  }
	.zz1_TopNavigationMenu_3 { border-style:none; }
	.zz1_TopNavigationMenu_4 {  }
	.zz1_TopNavigationMenu_5 { border-style:none; }
	.zz1_TopNavigationMenu_6 {  }
	.zz1_TopNavigationMenu_7 {  }
	.zz1_TopNavigationMenu_8 { border-style:none; }
	.zz1_TopNavigationMenu_9 {  }
	.zz1_TopNavigationMenu_10 { border-style:none; }
	.zz1_TopNavigationMenu_11 {  }
	.zz1_TopNavigationMenu_12 { border-style:none; }
	.zz1_TopNavigationMenu_13 {  }
	.zz1_TopNavigationMenu_14 { border-style:none; }
	.zz1_TopNavigationMenu_15 { background-color:#CBE3F0; }
	.ctl00_PlaceHolderMain_LeftColZone_0 { border-color:Black;border-width:1px;border-style:Solid; }
	.ctl00_PlaceHolderMain_LoginZone_0 { border-color:Black;border-width:1px;border-style:Solid; }
	.ctl00_PlaceHolderMain_RightColZone_0 { border-color:Black;border-width:1px;border-style:Solid; }
</style></head><body style="background:url(../../Style%20Library/DSM_Images/background.gif) repeat-x;margin:0px;" scroll="yes" onload="javascript:if (typeof(_spBodyOnLoadWrapper) != 'undefined') _spBodyOnLoadWrapper();"><form name="aspnetForm" method="post" action="../../ProposedRevisions/Pages/proposedrevision_rid_557.html" id="aspnetForm">
<input type="hidden" name="MSO_PageHashCode" id="MSO_PageHashCode" value="3895-1381814568"/>
<input type="hidden" name="__SPSCEditMenu" id="__SPSCEditMenu" value="true"/>
<input type="hidden" name="MSOWebPartPage_PostbackSource" id="MSOWebPartPage_PostbackSource" value=""/>
<input type="hidden" name="MSOTlPn_SelectedWpId" id="MSOTlPn_SelectedWpId" value=""/>
<input type="hidden" name="MSOTlPn_View" id="MSOTlPn_View" value="0"/>
<input type="hidden" name="MSOTlPn_ShowSettings" id="MSOTlPn_ShowSettings" value="False"/>
<input type="hidden" name="MSOGallery_SelectedLibrary" id="MSOGallery_SelectedLibrary" value=""/>
<input type="hidden" name="MSOGallery_FilterString" id="MSOGallery_FilterString" value=""/>
<input type="hidden" name="MSOTlPn_Button" id="MSOTlPn_Button" value="none"/>
<input type="hidden" name="__REQUESTDIGEST" id="__REQUESTDIGEST" value="0xCF7CD8AB93B1EC6CDADA830030E66A9AC3789BDC2EBDDC4B906245607328C424945AA6CC6EC9F849EC4D14217F26B2B43B4B9A1609F74436700C9CCAA1E035CF,19 Oct 2012 20:36:02 -0000"/>
<input type="hidden" name="MSOAuthoringConsole_FormContext" id="MSOAuthoringConsole_FormContext" value=""/>
<input type="hidden" name="MSOAC_EditDuringWorkflow" id="MSOAC_EditDuringWorkflow" value=""/>
<input type="hidden" name="MSOSPWebPartManager_DisplayModeName" id="MSOSPWebPartManager_DisplayModeName" value="Browse"/>
<input type="hidden" name="MSOWebPartPage_Shared" id="MSOWebPartPage_Shared" value=""/>
<input type="hidden" name="MSOLayout_LayoutChanges" id="MSOLayout_LayoutChanges" value=""/>
<input type="hidden" name="MSOLayout_InDesignMode" id="MSOLayout_InDesignMode" value=""/>
<input type="hidden" name="MSOSPWebPartManager_OldDisplayModeName" id="MSOSPWebPartManager_OldDisplayModeName" value="Browse"/>
<input type="hidden" name="MSOSPWebPartManager_StartWebPartEditingName" id="MSOSPWebPartManager_StartWebPartEditingName" value="false"/>
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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"/>
<script> var MSOWebPartPageFormName = 'aspnetForm';</script>
<script type="text/javascript">
//<![CDATA[
                function DoCallBack(filterText)
                {
                    WebForm_DoCallback('ctl00$m$g_3f2d429f_e45d_4299_8ebf_e8597f5fcbab',filterText,UpdateFilterCallback,0,CallBackError,true);
                }
                function CallBackError(result, clientsideString)
                {                
                }
            //]]>
</script>
<script type="text/JavaScript" language="JavaScript">
<!--
var L_Menu_BaseUrl="/ProposedRevisions";
var L_Menu_LCID="1033";
var L_Menu_SiteTheme="";
//-->
</script>
<script type="text/javascript">
//<![CDATA[
var globalArg_g_8bd325df_1ef5_4c59_9cf9_133a68ebd1c0;
var globalContext_g_8bd325df_1ef5_4c59_9cf9_133a68ebd1c0;
function ExpGroupCallServerg_8bd325df_1ef5_4c59_9cf9_133a68ebd1c0(arg, context)
{
    globalArg_g_8bd325df_1ef5_4c59_9cf9_133a68ebd1c0 = "GroupString=" + arg + "&ConnectionFilterString=";
    globalContext_g_8bd325df_1ef5_4c59_9cf9_133a68ebd1c0 = context;
    setTimeout("WebForm_DoCallback('ctl00$m$g_8bd325df_1ef5_4c59_9cf9_133a68ebd1c0',globalArg_g_8bd325df_1ef5_4c59_9cf9_133a68ebd1c0,ExpGroupReceiveData,globalContext_g_8bd325df_1ef5_4c59_9cf9_133a68ebd1c0,ExpGroupOnError,true)", 0);
}
function ExpGroupOnError(message, context) {
alert('An error has occurred with the data fetch.  Please refresh the page and retry.');
}
if (typeof(_spBodyOnLoadFunctionNames) != "undefined") {
if (_spBodyOnLoadFunctionNames != null) {
_spBodyOnLoadFunctionNames.push("ExpGroupOnPageLoad");
}
}//]]>
</script>
<script src="../../WebResource.axd_d_T_sWwmChWv5_0o-vuzl71g2_t_633965588901821931.js" type="text/javascript"></script>
<input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="/wEWBALpvL+GCgKh5+UkAq/TrIoDAqrQ2/8GVXSXQ46NfdCJtpNprunOQfFyw9o="/>
<!-- begin MAIN LAYOUT -->
		<div id="DSM_MainContainer">
			<div id="DSM_Header">	
	<!---- begin ACCESSIBILITY FEATURE ---->
					<div id="TurnOnAccessibility" style="display:none">
			   		<a href="#" class="ms-skip" onclick="SetIsAccessibilityFeatureEnabled(true);UpdateAccessibilityUI();return false;">
					Turn on more accessible mode</a></div>
					<a href="javascript:;" onclick="javascript:this.href='#mainContent';" class="ms-skip" accesskey="J">
					Skip to main content</a>
			  		<div id="TurnOffAccessibility" style="display:none">
					<a href="#" class="ms-acclink" onclick="SetIsAccessibilityFeatureEnabled(false);UpdateAccessibilityUI();return false;">
					Turn off more accessible mode</a></div>
	<!---- end ACCESSIBILITY FEATURE ---->
	<!-- begin UPPER BAR for SITE ACTIONS and EDITING ELEMENTS -->
	<div id="SP_adminBar">
		<tr><td colspan="4" id="mpdmconsole" class="ms-consolemptablerow">
<!-- Console -->
<span id="ctl00_SPNavigation_ctl01_publishingContext1"></span>
<!-- Console -->
</td></tr>
	</div>
<!-- end UPPER BAR for SITE ACTIONS and EDITING ELEMENTS -->
				<h1><a href="/">American Psychiatric Association DSM-5 Development</a></h1>	
				<div id="DSM_UtilityLinks"><a href="http://www.psychiatry.org/">www.psychiatry.org</a></div>
				<!--<div id="DSM_UtilityLinks3"><a href="/pages/registration.aspx">Volunteer for Field Trials</a></div>-->
				<div id="DSM_UtilityLinks2"><a href="../../Pages/TermsandConditionsofUse.html">Terms and Conditions of Use</a></div>
				<div id="DSM_SearchForm">
					<table>
						<tr>
							<td><input type="text" id="searchTerm" onkeydown="searchSubmitEnter()"/></td>
							<td><img src="../../Style Library/DSM_Images/search.gif" alt="Search" id="searchBtn" onclick="searchSubmitClick()"/></td>
						</tr>
					</table>					
				</div>			
			</div>	
			<div id="DSM_TopNavBar">
<!---- begin TOP NAVIGATION ---->		
			<table id="zz1_TopNavigationMenu" class="ms-topNavContainer zz1_TopNavigationMenu_2" cellpadding="0" cellspacing="0" border="0">
	<tr>
		<td onmouseover="Menu_HoverRoot(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun0"><table class="DSM_staticNavItem zz1_TopNavigationMenu_4 DSM_staticNavSelected zz1_TopNavigationMenu_9" cellpadding="0" cellspacing="0" border="0" width="100%">
			<tr>
				<td><a class="zz1_TopNavigationMenu_1 DSM_staticNavItem zz1_TopNavigationMenu_3 DSM_staticNavSelected zz1_TopNavigationMenu_8" href="/" accesskey="1">Home</a></td>
			</tr>
		</table></td><td width="0"></td><td><table border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="About DSM-5" id="zz1_TopNavigationMenun1"><table class="DSM_staticNavItem zz1_TopNavigationMenu_4" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="zz1_TopNavigationMenu_1 DSM_staticNavItem zz1_TopNavigationMenu_3" href="../../about/Pages/Default.html">About DSM-5</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Meet Us" id="zz1_TopNavigationMenun2"><table class="DSM_staticNavItem zz1_TopNavigationMenu_4" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="zz1_TopNavigationMenu_1 DSM_staticNavItem zz1_TopNavigationMenu_3" href="../../MeetUs/Pages/Default.html">Meet Us</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Research Background" id="zz1_TopNavigationMenun3"><table class="DSM_staticNavItem zz1_TopNavigationMenu_4" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="zz1_TopNavigationMenu_1 DSM_staticNavItem zz1_TopNavigationMenu_3" href="../../Research/Pages/Default.html">Research Background</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="General Resources" id="zz1_TopNavigationMenun4"><table class="DSM_staticNavItem zz1_TopNavigationMenu_4" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="zz1_TopNavigationMenu_1 DSM_staticNavItem zz1_TopNavigationMenu_3" href="../../ProgressReports/Pages/Default.html">General Resources</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="DSM-5 Proposed Revisions" id="zz1_TopNavigationMenun5"><table class="DSM_staticNavItem zz1_TopNavigationMenu_4" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="zz1_TopNavigationMenu_1 DSM_staticNavItem zz1_TopNavigationMenu_3" href="../../proposedrevision/Pages/Default.html">Proposed Revisions</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Newsroom" id="zz1_TopNavigationMenun6"><table class="DSM_staticNavItem zz1_TopNavigationMenu_4" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="zz1_TopNavigationMenu_1 DSM_staticNavItem zz1_TopNavigationMenu_3" href="../../Newsroom/Pages/Default.html">Newsroom</a></td>
					</tr>
				</table></td><td width="0"></td>
			</tr>
		</table><div id="zz1_TopNavigationMenun1Items" class="zz1_TopNavigationMenu_0 DSM_dynamicNav zz1_TopNavigationMenu_7">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="DSM-V Overview" id="zz1_TopNavigationMenun7">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../about/Pages/DSMVOverview.html">DSM-5 Overview: The Future Manual</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Timeline" id="zz1_TopNavigationMenun8">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../about/Pages/Timeline.html">Timeline</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Board of Trustee Principles" id="zz1_TopNavigationMenun9">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../about/Pages/BoardofTrusteePrinciples.html">Board of Trustee Principles</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Frequently Asked Questions" id="zz1_TopNavigationMenun10">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../about/Pages/faq.html">Frequently Asked Questions</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun1ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun1ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun2Items" class="zz1_TopNavigationMenu_0 DSM_dynamicNav zz1_TopNavigationMenu_7">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Task Force Members" id="zz1_TopNavigationMenun11">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../MeetUs/Pages/TaskForceMembers.html">Task Force Members</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Study Group Members" id="zz1_TopNavigationMenun12">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../MeetUs/Pages/StudyGroupMembers.html">Study Group Members</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Work Group Members" id="zz1_TopNavigationMenun13">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../MeetUs/Pages/WorkGroupMembers.html">Work Group Members</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun14">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../about/Pages/BoardofTrusteePrinciples.html">Board of Trustee Principles</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun2ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun2ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun3Items" class="zz1_TopNavigationMenu_0 DSM_dynamicNav zz1_TopNavigationMenu_7">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun15">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../Research/Pages/ConferenceSummariesandMonographs.html">DSM-5 Research Planning Conference Summaries and Monographs</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun16">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../Research/Pages/Presentations.html">Presentations on DSM-5 and Related Topics</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun17">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../Research/Pages/Publications.html">Publications from DSM-5 Development</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun18">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../Research/Pages/DSM-5FieldTrials.html">DSM-5 Field Trials</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun3ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun3ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun5Items" class="zz1_TopNavigationMenu_0 DSM_dynamicNav zz1_TopNavigationMenu_7">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Neurodevelopmental Disorders" id="zz1_TopNavigationMenun19">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/NeurodevelopmentalDisorders.html">Neurodevelopmental Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Schizophrenia Spectrum and Other Psychotic Disorders" id="zz1_TopNavigationMenun20">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/SchizophreniaSpectrumandOtherPsychoticDisorders.html">Schizophrenia Spectrum and Other Psychotic Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Bipolar and Related Disorders" id="zz1_TopNavigationMenun21">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/BipolarandRelatedDisorders.html">Bipolar and Related Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Depressive Disorders" id="zz1_TopNavigationMenun22">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/DepressiveDisorders.html">Depressive Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Anxiety Disorders" id="zz1_TopNavigationMenun23">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/AnxietyDisorders.html">Anxiety Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Obsessive-Compulsive and Related Disorders" id="zz1_TopNavigationMenun24">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/Obsessive-CompulsiveandRelatedDisorders.html">Obsessive-Compulsive and Related Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Trauma and Stressor Related Disorders" id="zz1_TopNavigationMenun25">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/TraumaandStressorRelatedDisorders.html">Trauma- and Stressor-Related Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Dissociative Disorders" id="zz1_TopNavigationMenun26">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/DissociativeDisorders.html">Dissociative Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Somatic Symptom Disorders" id="zz1_TopNavigationMenun27">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/SomaticSymptomDisorders.html">Somatic Symptom Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Feeding and Eating Disorders" id="zz1_TopNavigationMenun28">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/FeedingandEatingDisorders.html">Feeding and Eating Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Elimination Disorders" id="zz1_TopNavigationMenun29">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/EliminationDisorders.html">Elimination Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Sleep-Wake Disorders" id="zz1_TopNavigationMenun30">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/Sleep-WakeDisorders.html">Sleep-Wake Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Sexual Dysfunctions" id="zz1_TopNavigationMenun31">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/SexualDysfunctions.html">Sexual Dysfunctions</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Gender Dysphoria" id="zz1_TopNavigationMenun32">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/GenderDysphoria.html">Gender Dysphoria</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Disruptive, Impulse Control, and Conduct Disorders" id="zz1_TopNavigationMenun33">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/Disruptive_ImpulseControl_andConductDisorders.html">Disruptive, Impulse Control, and Conduct Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Substance Use and Addictive Disorders" id="zz1_TopNavigationMenun34">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/SubstanceUseandAddictiveDisorders.html">Substance Use and Addictive Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Neurocognitive Disorders" id="zz1_TopNavigationMenun35">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/NeurocognitiveDisorders.html">Neurocognitive Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Personality Disorders" id="zz1_TopNavigationMenun36">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/PersonalityDisorders.html">Personality Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Paraphilic Disorders" id="zz1_TopNavigationMenun37">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/ParaphilicDisorders.html">Paraphilic Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Other Disorders" id="zz1_TopNavigationMenun38">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/OtherDisorders.html">Other Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Proposed DSM-5 Organizational Structure and Disorder Names" id="zz1_TopNavigationMenun39">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/proposed-dsm5-organizational-structure-and-disorder-names.html">Proposed DSM-5 Organizational Structure and Disorder Names</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Proposed Mental Disorder Definitions" id="zz1_TopNavigationMenun40">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/proposedrevision_rid_465.html">Proposed Mental Disorder Definitions</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun41">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/Cult.html">DSM-5 Cultural Formulation Interview</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun5ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun5ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun6Items" class="zz1_TopNavigationMenu_0 DSM_dynamicNav zz1_TopNavigationMenu_7">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun42">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../Newsroom/Pages/PressReleases.html">Press Releases</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun43">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../Newsroom/Pages/MediaContact.html">Media Contact</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="FAQ" id="zz1_TopNavigationMenun44">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../about/Pages/faq.html">Frequently Asked Questions</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun45">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../Newsroom/Pages/Commentaries.html">Commentaries, Responses, and Other DSM-5 News </a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun6ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun6ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div></td>
	</tr>
</table>
<!---- end TOP NAVIGATION ---->
		</div>
			<div id="DSM_MainContent">
<!---- begin MAIN CONTENT AREA ---->
		<a name="mainContent"></a>
	<div id="DSM_LeftCol">	
		<div id="DSM_Breadcrumbs">
			<span id="ctl00_PlaceHolderMain_siteMapPath"><a href="#ctl00_PlaceHolderMain_siteMapPath_SkipLink"><img alt="Skip Navigation Links" height="0" width="0" src="../../WebResource.axd_d_nmHMzpcb8opA4_TBGiLLxg2_t_633965588901821931.jpg" border="0"/></a><span><a class="DSM_bcNode" href="/">Home</a></span><span class="DSM_bcSeparator"> / </span><span><a title="Proposed Revisions" class="DSM_bcNode" href="../../ProposedRevisions/Pages/Default.html">Proposed Revisions</a></span><span class="DSM_bcSeparator"> / </span><span class="DSM_bcCurrent">Proposed Revision</span><a id="ctl00_PlaceHolderMain_siteMapPath_SkipLink"></a></span>		
		</div>									
		<table width="100%" cellpadding="0" cellspacing="0" border="0">
	<tr>
		<td id="MSOZoneCell_WebPartWPQ2" valign="top"><table toplevel border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td valign="top"><div webpartid="3f2d429f-e45d-4299-8ebf-e8597f5fcbab" haspers="false" id="WebPartWPQ2" width="100%" allowdelete="false" style=""><table border="0" width="100%" xmlns:x="http://www.w3.org/2001/XMLSchema" xmlns:d="http://schemas.microsoft.com/sharepoint/dsp" xmlns:asp="http://schemas.microsoft.com/ASPNET/20" xmlns:__designer="http://schemas.microsoft.com/WebParts/v2/DataView/designer" xmlns:sharepoint="Microsoft.SharePoint.WebControls" xmlns:ddwrt2="urn:frontpage:internal"><tr><td><table border="0" cellspacing="0" width="100%"><tr><td><h1><span><br>Caffeine Use Disorder </span></h1><div class="DSM_TabBar"><ul><li><a href="#" id="DSM_Tab_Proposed" class="DSM_TabOn" onclick="TabClick('Proposed','Rationale','Severity','DSM-IV')">Proposed   
								&nbsp;Revision</a></li><li><a href="#" id="DSM_Tab_Rationale" class="DSM_TabOff" onclick="TabClick('Rationale','Proposed','Severity','DSM-IV')">Rationale</a></li><li><a href="#" id="DSM_Tab_Severity" class="DSM_TabOff" onclick="TabClick('Severity','Proposed','Rationale','DSM-IV')">Severity</a></li><li><a href="#" id="DSM_Tab_DSM-IV" class="DSM_TabOff" onclick="TabClick('DSM-IV','Proposed','Rationale','Severity')">DSM-IV</a></li></ul><div class="DSM_clear"><img src="../../Style Library/DSM_Images/clear.gif" width="0" height="0" alt=""></div></div><div id="DSM_TabContent_Proposed"><p><strong>CAFFEINE USE DISORDER</strong></p>
<p align="right"><em>Updated April 30, 2012</em><span style="font-family:'arial','sans-serif';font-size:10pt"><span style="font-family:'arial','sans-serif';font-size:10pt">  </p>
<p style="text-indent:-13.5pt;margin-left:13.5pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">A.  A maladaptive pattern of caffeine use leading to clinically significant impairment or distress, as manifested by 2 (or more) of the following, occurring within a 12-month period: </span></p>
<p class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p style="text-indent:-0.25in;margin-left:31.5pt" class="MsoListParagraphCxSpFirst"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>1.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Caffeine is often taken in larger amounts or over a longer period than was intended </span></p>
<p style="margin-left:31.5pt" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p style="text-indent:-0.25in;margin-left:31.5pt" class="MsoListParagraphCxSpLast"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>2.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">There is a persistent desire or unsuccessful efforts to cut down or control caffeine use</span></p>
<p class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p style="text-indent:-0.25in;margin-left:31.5pt" class="MsoListParagraph"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>3.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">A great deal of time is spent in activities necessary to obtain caffeine, use caffeine, or recover from its effects</span></p>
<p class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p style="text-indent:-0.25in;margin-left:31.5pt" class="MsoListParagraph"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>4.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Recurrent caffeine use resulting in a failure to fulfill major role obligations at work, school, or home (e.g., repeated absences or poor work performance related to caffeine use; caffeine-related absences, suspensions, or expulsions from school; neglect of children or household)</span></p>
<p class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p style="text-indent:-0.25in;margin-left:31.5pt" class="MsoListParagraph"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>5.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Continued caffeine use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of caffeine (e.g., arguments with spouse about consequences of intoxication, cost, medical problems)</span></p>
<p class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p style="text-indent:-0.25in;margin-left:31.5pt" class="MsoListParagraph"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>6.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Important social, occupational, or recreational activities are given up or reduced because of caffeine use</span></p>
<p class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p style="text-indent:-0.25in;margin-left:31.5pt" class="MsoListParagraph"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>7.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Recurrent caffeine use in situations in which it is physically hazardous </span></p>
<p class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p style="text-indent:-0.25in;margin-left:31.5pt" class="MsoListParagraph"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>8.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Caffeine use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by caffeine</span></p>
<p class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p style="text-indent:-0.25in;margin-left:31.5pt" class="MsoListParagraphCxSpFirst"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>9.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Tolerance, as defined by either of the following: <span>                                                             </span></span></p>
<p style="text-indent:-0.25in;margin-left:31.5pt" class="MsoListParagraphCxSpFirst"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>        </span></span><span style="font-family:'arial','sans-serif';font-size:10pt">a. need for markedly increased amounts of caffeine to achieve desired effect </span></p>
<p style="margin-left:31.5pt" class="MsoListParagraphCxSpLast"><span style="font-family:'arial','sans-serif';font-size:10pt">b. markedly diminished effect with continued use of the same amount of caffeine</span></p>
<p class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p style="text-indent:-0.25in;margin-left:31.5pt" class="MsoListParagraphCxSpFirst"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>10.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Withdrawal, as manifested by either of the following: </span></p>
<p style="margin-left:31.5pt" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt">a. the characteristic withdrawal syndrome for caffeine </span></p>
<p style="margin-left:31.5pt" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt">b. caffeine (or a closely related) substance is taken to relieve or avoid withdrawal symptoms</span></p>
<p style="margin-left:31.5pt" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p style="margin-left:13.5pt" class="MsoListParagraphCxSpLast"><span style="font-family:'arial','sans-serif';font-size:10pt">11. Craving or a strong desire or urge to use caffeine.</span></p></span>
<p style="text-indent:-13.5pt;margin-left:13.5pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span style="font-family:'arial','sans-serif';font-size:10pt">  </p>
<p class="MsoNormal"><b><u><span style="font-family:'arial','sans-serif';font-size:10pt">Specify the following:</span></u></b></p>
<p class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt"></span></b></p>
<p class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt">Early Remission.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt"> This specifier is used if, for at least 3 months, but for less than 12 months, the individual does not meet any of the criteria 1-10 for a Substance Use Disorder (i.e. none of the criteria except for Criterion 11, “Craving or a strong desire or urge to use a specific substance”).</span></p>
<p class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt">Sustained Remission.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt"> This specifier is used if none of the criteria 1-10 for a Substance Use Disorder have been met at any time during a period of 12 months or longer (i.e. none of the criteria met except for Criterion 11, “Craving or a strong desire or urge to use a specific substance”). </span></p>
<p class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><strong></strong></p>
<p class="MsoNormal"><span style="font-family:'arial','sans-serif';color:#333333;font-size:10pt"></span> </p>
<p class="MsoNormal"><span style="font-family:'arial','sans-serif';color:#333333;font-size:10pt">The following specifier applies as a further specifier of remission (e.g. “early remission in a controlled environment”, and “sustained remission in a controlled environment”) if the individual is in remission and in a controlled environment:</span><span style="font-family:'arial','sans-serif';color:blue;font-size:12pt"></span></p></span>
<p class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt">In a Controlled Environment.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt"> This additional specifier is used if the individual is in an environment where access to alcohol and controlled substances is restricted, and no criteria for a Substance Use Disorder have been met. Examples of these environments are closely supervised and substance-free jails, therapeutic communities, and locked hospital units. </span></p>
<p style="margin-left:9pt" class="MsoNormal"></span></span></span> </p></div><div id="DSM_TabContent_Rationale"><p align="right"><font size="2"><em>Updated April 30, 2012</em>  </font></p>
<p align="left"><strong><font size="2" face="Arial">Rationional for the Proposed Changes to Caffeine Use Disorder</font></strong></p>
<p align="left"><b><span></span></b><font size="2" face="Arial"> </font></p>
<p align="left"><font size="2" face="Arial"></font>
<p style="text-indent:0in" class="MsoBodyTextIndent"><b><u><span><span style="text-decoration:none"><font size="2" face="Arial"></font></span></span></u></b></p><font face="Arial"><font size="2"><b><u><span>I.<span>  </span>Need for the Category</span></u></b><b><span> </span></b></font></font>
<p></p>
<p style="text-indent:19.95pt" class="MsoBodyTextIndent"><span><font size="2" face="Arial">DSM-IV-TR states, “A diagnosis of Substance Dependence can be applied to every class of substances except caffeine” (APA 2000).<span>  </span>However, a diagnosis of substance dependence due to caffeine is recognized by ICD-10 (WHO 1992a, 1992b), which uses very similar diagnostic criteria to DSM-IV-TR.<span style="letter-spacing:-0.15pt"><span>  </span></span>In describing the DSM-IV Work Group’s decision to explicitly exclude a diagnosis of caffeine dependence from DSM-IV, Hughes (1994) indicated that although substantial basic research data exist for the disorders of caffeine dependence and abuse (Hughes et al., 1992), a clinical data base was missing. Clinical data that would be necessary for the inclusion of caffeine dependence included empirical evidence that a substantial proportion of caffeine users 1. try to stop and cannot, 2. have difficultly switching to decaffeinated products, and 3. use caffeine despite having knowledge that they have a health problem aggravated by caffeine. It was concluded that further research into caffeine dependence and abuse was especially important given recent evidence that chronic caffeine use might potentiate other substance abuse disorders and psychiatric disorders (Hughes, 1994).<span>  </span>Research has accumulated to support the consideration of including a Caffeine Use Disorder. </font></span></p>
<p style="text-indent:19.95pt" class="MsoBodyTextIndent"><span><font face="Arial"><font size="2">The great majority of the research literature on caffeine dependence has been published since the DSM-IV Work Group (in 1994) formulated its criteria for proposed research diagnoses (Hughes et al. 1992).<span>  </span>Several recent reviews provide a current analysis of this literature and have been used as the bases of this report (Satel 2006; Ogawa and Ueki 2007; Griffiths and Ressig, 2008; Juliano and Griffiths, 2009; <b>Juliano et al. in press).</b></font></font></span></p>
<p style="line-height:normal;page-break-after:auto;text-indent:20.15pt" class="MsoHeading7"><span style="font-weight:normal"><font size="2" face="Arial">A substantial number of studies and reports now demonstrate that a nontrivial proportion of chronic caffeine users develop features of a substance dependence syndrome on caffeine.<span>  </span>The syndrome includes the important and clinically significant features of continued use despite harm, unsuccessful efforts to cut down or quit caffeine, and continued use to avoid withdrawal symptoms.<span>  </span>Some individuals with caffeine dependence are sufficiently distressed to seek treatment. </font></span></p>
<p style="text-indent:19.95pt" class="MsoBodyTextIndent"><span><span><font size="2" face="Arial"> </font></span></span></p>
<p style="text-indent:19.95pt" class="MsoBodyTextIndent"><font face="Arial"><font size="2"><i><u><span>Biological Plausibility. </span></u></i><span>Antagonism of the endogenous neuromodulator adenosine at adenosine receptors is the primary cellular mechanism underlying most of the effects of caffeine, including the mood and performance stimulant effects as well as the physiological effects and symptoms accompanying caffeine abstinence.<span>  </span>Considerable data also suggest that the central stimulant effects of caffeine may be dopaminergically mediated (Ferré et al., 1997; Fredholm et al. 1999; Ferré 2008).<span>  </span>More specifically, it is established that caffeine enhances dopaminergic activity by competitive antagonism of central adenosine receptors that are colocalized and functionally interact with dopamine receptors.<span>  </span>As a competitive antagonist at adenosine receptors, caffeine is believed to produce most of its low- to moderate-dose stimulant behavioral effects by removing the negative modulatory effects of adenosine from dopamine receptors, thus stimulating dopaminergic activity (Ferré 2008).<span>  </span>Furthermore, dopamine release in the nucleus accumbens shell has been proposed as a specific neuropharmacological mechanism underlying the addictive potential of many drugs including the abused stimulants , and in vivo microdialysis studies have shown an increase in dopamine release in the nucleus accumbens shell after local or systemic administration of caffeine (e.g. Solinas et al. 2002</span><span>, Quarta et al. 2004a,b)</span><span>.<span>  </span>The failure of some studies to reproduce these findings was shown to be related to a more restricted caffeine-responsive area in the nucleus accumbens shell (Borycz et al., 2007).<span>  </span>Thus, although caffeine is a less efficacious behavioral stimulant than cocaine and amphetamine, it appears to share the common mechanism of increased dopaminergic activity with these classic stimulant drugs of abuse (<b>cf. Juliano et al., in press</b>). <i><u></u></i></span></font></font></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><span style="font-weight:normal"><font face="Arial"><font size="2">Many studies have shown that caffeine in low to moderate doses (20–200 mg) produces mild positive subjective effects of increased feelings of well-being, alertness, energy, concentration, self-confidence, motivation for work, and desire to talk to people (Griffiths et al., 2003). The profile of positive effects with caffeine is qualitatively similar to that produced by <i>d</i>-amphetamine and cocaine, which may reflect a common dopaminergic mechanism of action.<span>  </span>Consistent with its ability to produce mild positive subjective effects, low to moderate doses of caffeine have also been shown to function as a reinforcer in humans—that is, when given the choice under experimental conditions, some people will consistently choose to consume caffeine rather than placebo (Griffiths and Ressig, 2008).<span>  </span>Those who choose caffeine tend to report positive subjective effects from caffeine, while nonchoosers report negative subjective effects (Goldstein et al. 1969, Evans and Griffiths 1992).<span>  </span></font></font></span></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><font face="Arial"><font size="2"><span style="font-weight:normal">Research indicates that avoidance of abstinence-associated withdrawal symptoms plays a central role in the development of habitual patterns of consumption of caffeine.<span>  </span>This relationship has been shown in retrospective questionnaire studies </span><span style="font-weight:normal">(Goldstein and Kaizer 1969)</span><span style="font-weight:normal"> and consistently in double-blind experimental studies that assessed direct behavioral measures of caffeine reinforcement or preference </span><span style="font-weight:normal">(Griffiths et al. 1986; Hughes et al. 1993; Liguori and Hughes 1997; Schuh and Griffiths 1997; Garrett and Griffiths 1998)</span><span style="font-weight:normal"> and beverage flavor preferences </span><span style="font-weight:normal">(Rogers et al. 1995; Yeomans et al. 1998; Yeomans et al. 2000; Yeomans et al. 2001; Yeomans et al. 2002; Tinley et al. 2003)</span><span style="font-weight:normal">.<span>  </span>One study of caffeine reinforcement, for example, showed that moderate caffeine consumers who reported caffeine withdrawal symptoms (i.e., headache, drowsiness) after drinking decaffeinated coffee were more than twice as likely to choose caffeinated over decaffeinated coffee in choice tests </span><span style="font-weight:normal">(Hughes et al. 1993)</span><span style="font-weight:normal">.<span>  </span>In studies that prospectively manipulated caffeine physical dependence, subjects chose caffeine more than twice as often when they were physically dependent than when they were not physically dependent </span><span style="font-weight:normal">(Griffiths et al. 1986; Garrett and Griffiths 1998)</span><span style="font-weight:normal">.<span>  </span>There is reasonable evidence to suggest that the neuropharmacological mechanism underlying caffeine withdrawal is that chronic caffeine administration produces compensatory upregulation of the adenosine system, resulting in an increase in functional sensitivity to adenosine during caffeine withdrawal.(Griffiths and Ressig 2008)</span></font></font></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><span style="font-weight:normal"><font face="Arial"><font size="2">Most drug dependencies are influenced, in part, by genotype.<span>  </span>Twin studies comparing monozygotic and dizygotic twins showed heritabilities of heavy caffeine use, caffeine tolerance, and caffeine withdrawal that ranged between 35% and 77% (Kendler and Prescott 1999, Swan et al. 1997, Pedersen 1981, Partanen et al. 1966).<span>  </span>Other twin studies examining caffeine use, alcohol use, and cigarette smoking concluded that a common genetic factor (polysubstance use) underlies the use of these three substances, with 28 to 41% of the heritable effects of caffeine use (or heavy use) shared with alcohol and smoking (Swan et al. 1997, Hettema et al. 1999).<span>  </span><span style="letter-spacing:-0.15pt">Recent studies of twin pairs found that caffeine and nicotine use and dependence were associated and substantially influenced by genetic factors unique to these licit drugs (Kendler et al. 2007, 2008).<span>  </span>In these studies, the magnitude of heritability is similar for caffeine dependence markers to that for alcohol and nicotine dependence markers.</span></font></font></span></p>
<p style="text-align:left" class="WordSection1" align="left"><span><font face="Arial"><font size="2"><span>            </span><b>Prevalence of Caffeine Dependence Diagnosis and Rates of Endorsement of SpecificDiagnostic Criteria. </b><span style="letter-spacing:-0.15pt">Several studies provide information about the prevalence of caffeine dependence and rates of endorsement of specific diagnostic criteria in different populations (Table 2).<span>  </span>The only general population study was that by Hughes et al., (1998b) who conducted</span> a random digit-dial telephone survey of residents of Vermont.<span>  </span>Assessing the seven generic DSM-IV criteria for dependence, 30% of the 162 current caffeine users fulfilled criteria for a diagnosis of substance dependence by indicating that three or more dependence criteria were fulfilled during the past year.<span>  </span><span>            </span>Two studies provided information about caffeine dependence in special populations.<span>  </span>In the first of these, <b>Striley and Cottler (2007)</b> used a heterogeneous sample composed of high school and college students, drug treatment patients, and pain clinic patients.<span>  </span>Of the caffeine consumers (N=167), 35% fulfilled DSM-IV criteria for diagnosis of substance dependence on caffeine by indicating that three or more of the seven dependence criteria were fulfilled during the past year.<span>  </span>This study also compared the proportion of caffeine users who endorsed each specific diagnostic criterion for caffeine compared to alcohol users who endorsed each specific criterion.<span>  </span>Caffeine and alcohol users had the equivalent rate of not being able to quit.<span>  </span>Although alcohol users had higher rates of endorsing tolerance and use more than intended, caffeine users had significantly higher rates of endorsing use despite harm and withdrawal.<span>  </span>In a second special population study, Svikis et al. (2005) interviewed women seeking prenatal care from a private OB practice in a suburban community.<span>  </span>Among caffeine users (N=44), 57% fulfilled DSM-IV criteria for diagnosis of substance dependence sometime<span>  </span>during their lifetime by endorsing three or more of the seven dependence criteria.<span>  </span><b></b></font></font></span></p>
<p style="text-indent:19.95pt" class="MsoBodyTextIndent"><span><font size="2" face="Arial">Also shown in Table 2 are the results of four studies that examined only participants who endorsed three or more criteria for dependence <b>(Strain et al. 1994</b>, Oberstar et al. 2002, Richards et al. 2004, Jones and Lejuez 2005).<span>  </span>These studies, which specifically focused on cases of caffeine dependence, provided compelling clinical information about the dependence syndrome and its treatment.<span>  </span>Table 3 provides three illustrative cases caffeine dependence from a study of 74 individuals who were sufficiently distressed by their caffeine use to enroll in a caffeine dependence treatment study that required diagnostic interview, detailed record-keeping of their caffeine consumption, and repeated clinic visits over a 6-month period (Richards et al. 2004).</font></span></p>
<p style="text-indent:19.95pt" class="MsoBodyTextIndent"><span><font size="2" face="Arial">The rates of endorsement of the individual criteria varied widely across samples.<span>  </span>The two most commonly endorsed were desire/unsuccessful attempts to stop (39-93%) and use despite harm (43-94%, except for the general population study which was considerably lower).<span>  </span>Some investigators <b>(Strain et al. 1994)</b> have suggested that the four criteria that seem most face valid with application to caffeine are: use despite harm; unsuccessful efforts to control use; withdrawal; and tolerance. </font></span></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><span style="font-weight:normal"><font size="2" face="Arial">Establishing a caffeine use disorder diagnosis would increase recognition of this disorder thus increasing awareness among health care providers and the general population that some caffeine users want to but cannot stop caffeine use.<span>  </span>The lack of a caffeine use disorder diagnosis suggests that cessation of caffeine should be as easy, which the aforementioned data clearly indicate is not the case. <span> </span>Such recognition would lead to development of specific cessation strategies and interventions that could benefit a large number of individuals.</font></span></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><font face="Arial"><font size="2"><span style="font-weight:normal">While there are no studies that have specifically examined the course and natural history of caffeine use disorder, like other drug use disorder syndromes caffeine use disorder appears to be a chronic relapsing disorder.<span>  </span>In the study described above by </span><span>Strain et al. (1994)</span><span style="font-weight:normal"> and Richards et al. (2004), caffeine dependent participants reported recurrent efforts to discontinue caffeine use, with failures to discontinue use or frequent relapses.<span>  </span>It appears that those with caffeine dependence rarely seek treatment and this has been suggested to indicate a lack of clinical significance.<span>  </span>However, this has been true of several newly recognized disorders.<span>  </span>For example, few sought psychiatric help for social phobia until it was recognized as a DSM disorder.</span></font></font></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><span style="font-weight:normal"><span><font size="2" face="Arial"> </font></span></span></p>
<p style="text-indent:19.95pt" class="MsoBodyTextIndent"><span><font size="2" face="Arial"></font></span></p>
<p style="line-height:normal;page-break-after:auto" class="MsoHeading7"><font face="Arial"><font size="2"><u><span>2. Relationship with Other DSM-5 Diagnoses</span></u><span></span></font></font></p>
<p class="MsoNormal"><span><font face="Arial"><font size="2"><span>            </span>Caffeine use disorder would be distinct from other SUDs, as it is a unique licit substance, and is perceived very differently than the illicit stimulants that tend to be abused (cocaine, methamphetamine).<span>  </span>The DSM could consider combining all stimulant substances and include caffeine in a list of stimulant-like substances.<span>  </span>This would be similar to the ICD.<span>  </span>Either way, the DSM Committee would need to decide whether or not to include Caffeine Use Disorder in the manual.</font></font></span></p>
<p class="MsoNormal"><b><span><font size="2" face="Arial"></font></span></b> </p>
<p class="MsoNormal"><font face="Arial"><font size="2"><b><span>3.<span>  </span><u>Available Treatments</u></span></b><span> – Is there evidence that, if the diagnosis was included in DSM-5, any effective biological, psychological, or social treatments for this diagnosis could potentially be found? </span></font></font></p>
<p style="text-indent:0in" class="MsoBodyTextIndent"><span><font size="2" face="Arial"> </font></span></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><span style="font-weight:normal"><font size="2" face="Arial">A number of research studies illustrate the potential for availability treatments for caffeine use disorder.<span>  </span>Several studies with heavy, caffeine consumers (who presumably would have fulfilled criteria for caffeine use disorder) demonstrated efficacy of a structured caffeine reduction treatment program (i.e., caffeine fading) in achieving substantial reductions in caffeine consumption (James et al. 1985, 1988, Bernard et al. 1981, Foxx and Rubinoff 1979). <span> </span>Almost certainly, treatments based on the same behavioral principles as those developed for other SUD’s could be easily adapted for caffeine use disorder with similar positive results.</font></span></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><span style="font-weight:normal"><font face="Arial"><font size="2">Including caffeine use disorder would certainly increase clinicians’ attention to a disorder that may be causing patients significant distress, and perhaps lead to helpful advice or treatment interventions. <span>  </span>Likewise, establishing a diagnosis would increase the general populations awareness that caffeine use can get out of control and lead to problems, which may stimulate treatment seeking in those who have tried but can not successfully stop on their own.<span>  </span><span> </span></font></font></span></p>
<p class="MsoNormal"><span><font size="2" face="Arial"> </font></span></p>
<p style="text-align:left" class="WordSection1" align="left"><font face="Arial"><font size="2"><b><span>4. <u>Meets Criteria for a Mental (Psychiatric) Diagnosis</u> –</span></b><span><span>         </span>A brief description of the several DSM-IV substance dependence diagnostic criteria most relevant to understanding the clinical relevance of acaffeine use disorder is presented below.</span></font></font></p>
<p style="text-align:left" class="WordSection1" align="left"><b><span><font size="2" face="Arial"> </font></span></b></p>
<p style="line-height:normal;page-break-after:auto" class="MsoHeading7"><i><u><span style="font-weight:normal"><font size="2" face="Arial">Substance use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance</font></span></u></i></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><span style="font-weight:normal"><font face="Arial"><font size="2">Fourteen percent of caffeine users in a general population survey met this DSM-IV-TR criterion, with most (13%) reporting that a physician or counselor had advised them to stop or reduce caffeine use within the last year (Hughes et al. 1998b). Medical and psychological problems attributed to caffeine included heart, stomach and urinary problems, and complaints of anxiety, depression, insomnia, irritability, and difficulty thinking.<span>  </span></font></font></span></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><font face="Arial"><font size="2"><span style="font-weight:normal">Fifty-four percent of adolescents and adults caffeine users endorsed this criterion in the study of by </span><span>Striley and Cottler (2007</span><span style="font-weight:normal">).<span>  </span>Ten percent of the study sample reported having talked to a doctor about problems from use of caffeinated beverages, and 11% continued to drink caffeine after they knew a health problem could be made worse by caffeine.<span>  </span>Physical and psychological problems attributed to caffeine included: 11% fast or irregular heartbeat or chest pain; 16% stomach problems; 36% trouble falling or staying asleep; 19% feeling very anxious due to caffeine use; 10% feeling irritable or angry due to caffeine use.</span></font></font></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><span style="font-weight:normal"><font size="2" face="Arial">Forty-three percent of caffeine users endorsed this criterion in the study of pregnant women who had been advised to quit caffeine use during pregnancy (Svikis et al. 2005).<span>  </span>When asked about caffeine use prior to pregnancy, 21% indicated that they had previously been told by a health care professional that they should cut back or quit caffeine because of a medical condition including, fibrocystic breast disease, headaches, pregnancy, insomnia, and stomach problems. </font></span></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><font face="Arial"><font size="2"><span style="font-weight:normal">As might be expected, higher rates of endorsement of continued use despite harm have been reported in studies of caffeine dependent individuals.<span>  </span>In four such studies, the prevalence was 57%, 58%, 94%, and 80%, respectively, in Jones and Lejuez 2005, Oberstar et al. 2002, </span><span>Strain et al. 1994</span><span style="font-weight:normal">, and Richards et al. 2004.<span>  </span>In the case series described by </span><span>Strain et al.,</span><span style="font-weight:normal"> 44% of the study subjects reported physical conditions such as pregnancy, palpitations, gastrointestinal problems, and acne rosacea that had led physicians to recommend reduction or elimination of caffeine.<span>  </span>All had failed to comply with the recommendation.<span>  </span>In the treatment study by Richards et al. (2004), 73% reported a physical problem (examples include stomach problems [e.g. heart burn, gastro-esophageal reflux], cardiovascular problems [e.g. palpitations, high blood pressure], frequent urination, insomnia, tremor; 58% reported a psychological problem (examples include anxiety, irritability, and anger problems); and 19% had been told by a physician or other medical professional that the problem was caused by caffeine.</span></font></font></p>
<p class="MsoNormal"><span><font size="2" face="Arial"> </font></span></p>
<p style="line-height:normal;page-break-after:auto" class="MsoHeading7"><font face="Arial"><font size="2"><i><u><span style="font-weight:normal">Persistent desire or unsuccessful efforts to cut down or control substance use</span></u></i><i><u><span></span></u></i></font></font></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><span style="font-weight:normal"><font face="Arial"><font size="2">The desire to control caffeine use is usually closely related to the recognition of an associated physical or psychological problem, often identified by a physician as described above.<span>  </span>In the three general population studies, the rate of endorsement of this DSM-IV-TR criterion was 56% (Hughes et al. 1998b), 39% (Striley and Cottler 2007), and 45% (Svikis et al. 2005).<span>  </span></font></font></span></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><span style="font-weight:normal"><font size="2" face="Arial">As might be expected, in the four studies of caffeine dependent individuals, the prevalence was higher (60%, 83%, 81%, and 93%, respectively, in Jones and Lejuez 2005, Oberstar et al. 2002, Strain et al. 1994, and Richards et al. 2004).<span>  </span>In the study by Richards et al., 74 individuals were sufficiently distressed by their caffeine use to enroll in a caffeine treatment study that required diagnostic interview, detailed record-keeping of their caffeine consumption, and repeated clinic visits over a 6-month period.</font></span></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><span style="font-weight:normal"><font size="2" face="Arial">In addition to the diagnostic assessment, Svikis et al. (2005) conducted a prospective study demonstrating the inability to quit caffeine use.<span>  </span>Pregnant women were given written and verbal instructions by a physician to quit caffeine during their pregnancy in order to avoid adverse birth consequences.<span>  </span>Of those who did not fulfill diagnostic criteria for caffeine dependence, none continued to consume caffeine in amounts greater than those thought to be safe during pregnancy (&gt;300 mg/day).<span>  </span>In contrast, 28% of women who fulfilled the caffeine dependence diagnosis continued to consume caffeine at unsafe levels.<span>  </span>Examples of reasons provided for failing to eliminate or cut back caffeine use included: cravings/headache/nervous; migraines; need to stay awake/headaches; severe withdrawal; and couldn’t concentrate at work.</font></span></p>
<p class="MsoNormal"><span><font size="2" face="Arial"> </font></span></p>
<p style="line-height:normal;page-break-after:auto" class="MsoHeading7"><font face="Arial"><font size="2"><i><u><span style="font-weight:normal">Withdrawal</span></u></i><i><span></span></i></font></font></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><font face="Arial"><font size="2"><span style="font-weight:normal">It is well documented that habitual caffeine users can experience a well-defined withdrawal syndrome upon acute abstinence from caffeine, and many caffeine dependent individuals report continuing to use caffeine to avoid experiencing withdrawal symptoms.<span>  </span>In the three general population studies, the rate of endorsement of the DSM-IV-TR withdrawal criterion (characteristic withdrawal syndrome or use of the substance to relieve or avoid withdrawal symptoms) was 18% (Hughes et al. 1998b), 40% (Striley and Cottler 2007), and 77% (Svikis et al. 2005).<span>  </span>As expected, in the four studies in caffeine dependent persons, the rate of endorsement of withdrawal or use to avoid withdrawal was higher (73%, 100%, 94%, and 92%, respectively, in Jones and Lejuez 2005, Oberstar et al. 2002, </span><span>Strain et al. 1994</span><span style="font-weight:normal">, and Richards et al. 2004).<span>  </span>Of the studies that provided this information, the rate of endorsement of the sub-criterion of use of substance to relieve or avoid withdrawal was 17% and 24% in two general population studies (respectively, Hughes et al. 1998b, and </span><span>Striley and Cottler 2007)</span><span style="font-weight:normal">, and 89% in a study of caffeine dependent individuals (Richards et al. 2004).</span></font></font></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><span style="font-weight:normal"><font face="Arial"><font size="2">As described in more detail in the background document on caffeine withdrawal previously submitted to this workgroup, symptoms of caffeine withdrawal can vary from none to significant clinical distress and functional impairment.<span>  </span>Based on a comprehensive review of the literature, the incidence of clinically significant distress or functional impairment in prospective experimental studies with normal subjects varied from about 10% to 55%, with a median of 13% (Juliano and Griffiths 2004).<span>  </span></font></font></span></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><font face="Arial"><font size="2"><span style="font-weight:normal">Some of the previously discussed caffeine diagnostic studies provided information about rates of functional impairment during withdrawal.<span>  </span>Hughes et al. (1998b) reported that 7% of those who cut down or stopped caffeine use temporarily and 24% of those who tried to stop permanently reported withdrawal symptoms plus interference with performance</span><span>.<span>  </span>Striley and Cottler (2007)</span><span style="font-weight:normal"> reported that 13% of their sample endorsed difficulty concentrating after 12 hours without caffeine.<span>  </span></span></font></font></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><font face="Arial"><font size="2"><span style="font-weight:normal">As might be expected, the rate of functional impairment is greater among those with a caffeine dependence diagnosis.<span>  </span>Oberstar et al. (2002) reported that 33% of caffeine dependent adolescents endorsed sick/nauseated/vomiting.<span>  </span>In the Richards et al. (2004) study, 50% of caffeine dependent subjects endorsed a history of withdrawal effects resulting in impairment of normal activities.<span>  </span>In addition to diagnostic assessment, </span><span>Strain et al. (1994)</span><span style="font-weight:normal"> provided a prospective experimental assessment of the rate of functional impairment during caffeine withdrawal in 11 caffeine dependent individuals.<span>  </span>That double-blind study showed that 73% of these subjects showed significant disruptions in normal daily activities during caffeine abstinence, including leaving or missing work, making errors or costly mistakes at work, inability to care for children, and inability to complete school work.</span></font></font></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><span style="font-weight:normal"><font size="2" face="Arial">Only one study has compared the severity of caffeine withdrawal to that of another drug of dependence.<span>  </span>Miyata et al. (2008) compared individuals who met DSM-IV-TR substance dependence criteria for either caffeine or nicotine before a controlled 7-day abstinence from their respective drug of dependence.<span>  </span>The results showed no differences between nicotine and caffeine in craving, or social functioning.<span>  </span>Although the incidence of irritability was higher with nicotine than caffeine, there were no differences in irritability on a well-being questionnaire.<span>  </span>The authors concluded that, overall, there were no meaningful differences between nicotine and caffeine in the difficulties of abstaining.</font></span></p>
<p style="text-indent:19.95pt" class="MsoNormal"><span><font size="2" face="Arial"> </font></span></p>
<p style="line-height:normal" class="MsoHeading7"><font face="Arial"><font size="2"><i><u><span style="font-weight:normal">Miscellaneous indicators of substance dependence</span></u></i><i><span></span></i></font></font></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><font face="Arial"><font size="2"><span style="font-weight:normal">Two surveys of the general population obtained information about two other substance dependence criteria that are included in other diagnostic surveys (e.g., ICD-9), but not included in DSM-IV-TR.<span>  </span>Hughes et al. (1998b) reported that 15% of caffeine consumers endorsed the ICD-9 criterion that drug use had become so regular that a person would not change when or how much they used, no matter what they were doing or where they were.<span>  </span>Nineteen percent and 33% (Hughes et al., 1998b, </span><span>Striley and Cottler 2007</span><span style="font-weight:normal">, respectively) of caffeine consumers endorsed the ICD-9 criterion of compulsive desire to use, that was defined as such a strong desire for drug that, at times, they could not resist it.<span>  </span>Miyata et al., (2008) reported similar peak elevations of craving during abstinence from caffeine and nicotine.</span></font></font></p>
<p class="MsoNormal"><span><font size="2" face="Arial"> </font></span></p>
<p class="MsoNormal"><i><u><span><font size="2" face="Arial">Reliability and validity of the diagnosis</font></span></u></i></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><font face="Arial"><font size="2"><span style="font-weight:normal">The one test-retest evaluation found high reliability of caffeine dependence (Hughes, 1997).<span>  </span>We know of no factor analyses of caffeine dependence criteria.<span>  </span>In the general population survey, only 37% of those who tried to stop all caffeine use were successful; however, whether success was related to endorsement of dependence symptoms was not stated.<span>  </span>In a prospective study of caffeine quitting during pregnancy (Svikis et al. 2005), women with caffeine dependence consumed significantly more caffeine than those without the diagnosis both before and throughout pregnancy; furthermore, throughout pregnancy 28% of caffeine dependent women continued to consume caffeine at unsafe levels in contrast to 0% of women who were not caffeine dependent.<span>  </span>A prospective study of caffeine withdrawal in caffeine dependent volunteers showed a 72% incidence of clinically significant withdrawal including functional impairment </span><span>(Strain et al. 1994)</span><span style="font-weight:normal">, which is substantially higher than the 13% in studies of unselected subject populations (Juliano and Griffiths 2004).<span>  </span>Finally, a small study of caffeine self-administration showed that subjects who had met criteria for caffeine dependence tended to be more likely to demonstrate reliable reinforcement (75%) than those who did not fulfill the diagnosis (20%) (Liguori and Hughes 1997). </span></font></font></p>
<h1 class="WordSection1"><b><span style="font-style:normal"><font size="2" face="Arial">Comorbidity Patterns </font></span></b></h1>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><span style="font-weight:normal"><font size="2" face="Arial">Consistent with the fact that drug dependence diagnoses are frequently associated with non-drug psychiatric disorders (Kleber et al. 2007), there are comorbid conditions associated with excessive caffeine consumption.<span>  </span>Surveys of psychiatric patients have found high rates of excessive caffeine consumption, particularly among patients with schizophrenia (Greden et al. 1978, Rihs et al. 1996, Hughes et al. 1998a; Strassnig et al., 2006, Gurpegui et al., 2006).<span>  </span>Excessive caffeine consumption may also exacerbate chronic psychiatric conditions (Winstead 1976, Zaslove et al. 1991, Tondo and Rudas 1991, De Freitas and Schwartz 1979, Mikkelsen 1978).<span>  </span>Excessive acute caffeine consumption can mimic panic attacks, while chronic caffeine consumption can mimic generalized anxiety (Uhde 1990).<span>  </span>Individuals with panic disorder report greater caffeine-induced anxiety than matched controls (Boulenger et al. 1984, Lee et al., 1985).<span>  </span>Experimental studies show that caffeine exacerbates anxiety symptoms in individuals with generalized anxiety disorder (Bruce et al, 1992) and panic disorder (Beck and Berisford 1992, Charney et al. 1985) more than in control subjects.<span>  </span>Genetic factors may underlie individual sensitivity to the anxiogenic effects of caffeine.<span>  </span>Genetic polymorphisms in the A2A receptor gene (ADORA2A) were shown in two studies to predict an anxiogenic response to 150 mg dose of caffeine among low caffeine consumers (Alsene et al. 2003; Childs et al. 2008).<span>  </span>Furthermore, first-degree relatives of patients with panic disorder also show heightened anxiogenic responses to high doses of caffeine (Nardi et al. 2007). </font></span></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><span style="font-weight:normal"><font size="2" face="Arial">Several studies provide information about comorbidity in individuals with caffeine dependence.<span>  </span>In a previously described study of 44 pregnant caffeine-using women (Svikis et al. 2005), those who had a caffeine dependence diagnosis were almost nine times more likely to report a history of daily cigarette smoking, compared to women without the diagnosis (44% vs. 5%).<span>  </span>Furthermore, women with both caffeine dependence and a family history of alcoholism were six times more likely to have a lifetime diagnosis of alcohol abuse or dependence. </font></span></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><font face="Arial"><font size="2"><span style="font-weight:normal">In the nosology study (N=167) by </span><span>Striley and Cottler (2007)</span><span style="font-weight:normal">, compared to individuals without a caffeine dependence diagnosis, individuals with the diagnosis were significantly more likely to be dependent on nicotine (88% vs. 69%) and alcohol (59% vs. 40%).</span></font></font></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><font face="Arial"><font size="2"><span style="font-weight:normal">In the study described above by </span><span>Strain et al. (1994)</span><span style="font-weight:normal">, which characterized caffeine dependence in 16 adults, it was found that two subjects (13%) had an additional current psychiatric diagnosis (both being anxiety disorders), and 69% had other psychiatric disorders in remission.<span>  </span>Most commonly, these other disorders were other psychoactive substance use disorders (63%) followed by mood disorders (44%), anxiety disorders (25%), or eating disorders (19%).<span>  </span>Among the psychoactive substance use disorders, the most commonly abused substance was alcohol; 57% of the participants in the study had a past diagnosis of alcohol abuse or dependence.<span>  </span>Five of the subjects in the study (32%) were cigarette smokers and, notably, four of these five had a history of an alcohol disorder (suggesting a clustering of caffeine dependence, smoking and alcohol abuse/dependence, as discussed below).<span>  </span></span></font></font></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><font face="Arial"><font size="2"><span style="font-weight:normal">A fourth study showed that the severity of caffeine dependence was significantly correlated with the severity of the alcohol dependence, however, dependence on caffeine and nicotine were not correlated (Hughes et al. 2000).<span>  </span>Although co-morbid psychiatric diagnoses are more common in individuals who are caffeine dependent, the studies reviewed above also indicate that caffeine dependence may occur in absence of any other current psychiatric diagnosis. <span> </span>For example, </span><span>Strain et al. (1994)</span><span style="font-weight:normal"> reported that of the 16 caffeine dependent individuals studied, 13% had a current psychiatric disorder other than cigarette smoking (31% were current cigarette smokers).<span>  </span>Furthermore, of 74 caffeine dependent individuals seeking treatment for caffeine dependence, only 35% had a lifetime diagnosis of an Axis I DSM-IV disorder, excluding simple phobias (Richards et al., 2004).<span>  </span></span><span></span></font></font></p>
<p style="line-height:normal;page-break-after:auto" class="MsoHeading7"><u><span><span style="text-decoration:none"><font size="2" face="Arial"> </font></span></span></u><span><font size="2" face="Arial">Summary of Evidence</font></span></p>
<p style="line-height:normal;page-break-after:auto;text-indent:19.95pt" class="MsoHeading7"><font face="Arial"><font size="2"><i><span style="font-weight:normal">Caffeine Use Disorder:</span></i><span style="font-weight:normal"><span>  </span>Caffeine intake causes neurobiological effects similar to that of other drugs of dependence; e.g. increased in dopaminergic function.<span>  </span>Like other drugs of abuse, caffeine use is influenced by genetic factors.<span>  </span>In addition, caffeine is a robust reinforcer in humans across doses, vehicles, populations, methods, etc.<span>  </span>Several surveys have shown a not-insignificant proportion of caffeine users endorse many of the generic dependence criteria when applied to caffeine; however, these studies have small sample sizes and there is no true national population-based survey.<span>  </span>On the other hand, case reports clearly indicate that there are some caffeine users who despite repeated sincere attempts to stop caffeine use cannot do so and suffer from their continued caffeine use.<span>  </span>Although limited by small sample sizes, the few studies that provide information about the predictive validity indicated that the caffeine dependence diagnosis predicted inability to quit caffeine use, a more severe withdrawal syndrome, and caffeine reinforcement.<span>  </span>Although few users have sought treatment, this may be due to the widespread availability of caffeine, and the low recognition that caffeine dependence could occur or that assistance to quit is available.<span>  </span>In summary, we believe there is sufficient evidence to warrant inclusion of caffeine dependence. </span></font></font></p>
<p class="MsoNormal"><span><font face="Arial"><font size="2">Sources:<sup> </sup></font></font></span></p>
<div class="WordSection2">
<p style="text-indent:-8.55pt;margin:0in -19.05pt 0pt 8.55pt" class="MsoNormal"><font face="Arial"><font size="2"><sup><span>a</span></sup><span> Hughes JR, Oliveto AH, Liguori A, Carpenter J, Howard T, (1998) Endorsement of DSM-IV dependence criteria among caffeine users. <i>Drug Alcohol Depend.</i> 52:99-107 </span></font></font></p>
<p style="text-indent:-8.55pt;margin:0in -19.05pt 0pt 8.55pt" class="MsoNormal"><font face="Arial"><font size="2"><sup><span>b</span></sup><span> Striley CLW, Cottler LB, (2007) <span>Adopting DSM-IV dependence criteria for caffeine: DSM-V implications</span>, paper presented at Symposium Caffeine as a gateway to addiction, College on Problems of Drug Dependence annual meeting, Quebec City, Canada, June 20, 2007.</span></font></font></p>
<p style="text-indent:-8.55pt;margin:0in -19.05pt 0pt 8.55pt" class="MsoNormal"><font face="Arial"><font size="2"><sup><span>c</span></sup><span> Svikis DS, Berger N, Haug NA, Griffiths RR, (2005) Caffeine dependence in combination with a family history of alcoholism as a predictor of continued use of caffeine during pregnancy. <i>Am J Psychiatry.</i> 162(12): 2344-2351; data presented are for Lifetime, not just past 12 months</span></font></font></p>
<p style="text-indent:-8.55pt;margin:0in -19.05pt 0pt 8.55pt" class="MsoNormal"><font face="Arial"><font size="2"><sup><span>d</span></sup><span> Jones HA , Lejuez CW (2005) Personality correlates of caffeine dependence: the role of sensation seeking, impulsivity, and risk taking. <i>Exp Clin Psychopharmacol.</i> 13(3): 259-266 </span></font></font></p>
<p style="text-indent:-8.55pt;margin:0in -19.05pt 0pt 8.55pt" class="MsoNormal"><font face="Arial"><font size="2"><sup><span>e</span></sup><span> Oberstar JV, Bernstein GA, Thuras PD (2002) Caffeine use and dependence in adolescents: one-year follow-up. <i>J Child Adolesc Psychopharmacol.</i> 12: 127<span style="color:black">-135</span> </span></font></font></p>
<p style="text-indent:-8.55pt;margin:0in -19.05pt 0pt 8.55pt" class="MsoBodyTextIndent"><span><font face="Arial"><font size="2"><span> </span><sup>f</sup> <span style="letter-spacing:-0.15pt">Strain EC, Mumford GK, Silverman K, Griffiths RR (1994) Caffeine dependence syndrome: evidence from case histories and experimental evaluations. <i>JAMA.</i> 272: 1043-1048</span></font></font></span></p>
<p style="text-indent:-8.55pt;margin:0in -19.05pt 0pt 8.55pt" class="MsoBodyTextIndent"><font face="Arial"><font size="2"><span style="letter-spacing:-0.15pt"><span> </span></span><sup><span>g</span></sup><span> Richards BD, Juliano LM, and Griffiths RR (2004) Characterization of individuals seeking treatment for caffeine dependence. Abstracts of the 66<sup>th</sup> Annual Meeting of the College on Problems of Drug Dependence 155. [data shown are from updated report in preparation, N=74]</span></font></font></p>
<p style="text-indent:-8.55pt;margin:0in -19.05pt 0pt 8.55pt" class="MsoBodyTextIndent"><span><font face="Arial"><font size="2"><span> </span>* Assessed only the four DSM-IV criteria for substance dependence that were thought to be most pertinent to a meaningful assessment of problematic caffeine use<span style="letter-spacing:-0.15pt"></span></font></font></span></p>
<p style="text-indent:0in;margin:0in -19.05pt 0pt 1.95pt" class="MsoBodyTextIndent"><span><font size="2" face="Arial"> </font></span></p></div><span><br style="page-break-before:always" clear="all"></span>
<p class="MsoNormal"><font face="Arial"><font size="2"><b><span>Table</span></b><span>: Illustrative cases of caffeine dependence.<span>  </span>Three cases of caffeine dependence from a study (Richards et al., 2004) of 74 individuals who were sufficiently distressed by their caffeine use to enroll in a caffeine treatment study that required diagnostic interview, detailed record-keeping of their caffeine consumption, and repeated clinic visits over a 6-month period.</span></font></font></p>
<p style="margin:0in 19.05pt 0pt 19.95pt" class="MsoNormal"><span><font size="2" face="Arial"> </font></span></p>
<p style="text-indent:-37.05pt;margin:0in 19.05pt 0pt 48.45pt" class="MsoNormal"><font face="Arial"><font size="2"><b><span>Case #1:</span></b><span> </span></font></font></p>
<p style="margin:0in 19.05pt 0pt 37.05pt" class="MsoNormal"><span><font size="2" face="Arial">Mr. B, a 27-year-old married man, presented with a chief complaint of severe headaches for which he took Excedrin multiple times daily.<span>  </span>Although he had a family history of migraine headache, he believed that his headaches were rebound headaches from the caffeine withdrawal.<span>  </span>He was a college graduate employed as a full-time elementary school teacher.<span>  </span>He did not smoke tobacco, or use illicit drugs and he drank alcohol occasionally.<span>  </span>Mr. B had an anxiety disorder for which he was taking prescription medication (Celexa and Clonopin daily, and Xanax as needed). </font></span></p>
<p style="margin-left:37.05pt" class="MsoBlockText"><span><font size="2" face="Arial">Mr. B began consuming caffeine regularly at age 18 primarily through soft drinks.<span>  </span>At age 27, the time of his screening evaluation, his usual daily caffeine use consisted of daily consumption of 3 caffeinated beverages (soda, coffee, and/or hot chocolate) along with 4 tablets of Excedrin which he took to treat his chronic headache.<span>  </span>He believed he was physically dependent on caffeine and he had been told by his family doctor that he should eliminate his caffeine use due to his severe headaches.<span>  </span>Mr. B was also concerned about possible toxicity from his chronic analgesic use.<span>  </span>His wife had also been concerned about his caffeine use.<span>  </span>He reported waking up during the night and almost every morning with a severe headache that he attributed to caffeine withdrawal due to not having had caffeine over the hours he was sleeping.<span>  </span>He had made two previous attempts to quit but in both cases quickly relapsed because of headaches and fatigue.<span>  </span>He contacted the caffeine dependence treatment program at Johns Hopkins after his wife saw an advertisement for a caffeine treatment study and encouraged him to participate.<span>  </span>In the screening interview, he stated that his goal for participation was to completely eliminate caffeine from his diet. </font></span></p>
<p style="margin-left:37.05pt" class="MsoBlockText"><span><font face="Arial"><font size="2">The caffeine dependence treatment program began with an interview about caffeine use and two weeks of keeping a daily caffeine diary.<span>  </span>This was followed by an individualized education and counseling session during which a gradual caffeine reduction plan was agreed upon.<span>  </span>Mr. B’s baseline caffeine intake from his caffeine diaries was 498 mg/day.<span>  </span>[Each Excedrin tablet contains 65 mg of caffeine, 250 mg of acetaminophen, and 250 mg of aspirin].<span>  </span>For the caffeinated beverages, the plan consisted of gradually reducing the amount consumed before moving on to reducing his Excedrin use.<span>  </span>He cut out his use of caffeinated beverages almost immediately.<span>  </span>Since much of his caffeine was coming from Excedrin, he reported that it was fairly easy for him to switch to decaffeinated beverages<b>.</b><span>  </span>The treatment strategy then consisted initially stopping the use of Excedrin and switching to use the individual component ingredients of Excedrin, which he obtained in a local pharmacy.<span>  </span>For the caffeine, he switched to a generic caffeine pill that he could cut using a pill cutter to obtain the desired amount of caffeine.<span>  </span>The plan consisted of initially gradually reducing the caffeine while maintaining his usual dosing of acetaminophen and aspirin so that caffeine withdrawal would not be confounded with termination of the analgesics.<span>  </span>He reported significant headaches only in the first few caffeine tapering weeks when he initially decreased his caffeine intake to 75% of previous levels.<span>  </span>He was instructed to increase his caffeine again to a level that controlled his withdrawal headaches, and then to decrease more gradually over about a 10 week period.<span>  </span>He successfully did this but departed from the treatment plan by concurrently decreasing his analgesic use after he began to experience success in eliminating the caffeine.<span>  </span>At the 6 month follow-up visit, he reported no regular use of caffeine or analgesics and no headaches from withdrawal.<span>  </span>When he did get a headache he was able to treat it with an OTC caffeine-free pain reliever.<span>  </span><b></b></font></font></span></p>
<p style="text-indent:-37.05pt;margin:0in 19.05pt 0pt 48.45pt" class="MsoNormal"><font face="Arial"><font size="2"><b><span>Case #2:</span></b><span> </span></font></font></p>
<p style="margin:0in 19.05pt 0pt 37.05pt" class="MsoNormal"><span><font size="2" face="Arial">Ms. B, a 46 year old married woman, presented to the caffeine dependence treatment clinic with complaints of sleep problems and occasional heart palpitations that she attributed to caffeine.<span>  </span>She also reported, fatigue, anxiety, and depressed mood when she abstained from caffeine.<span>  </span>Ms. B was a college graduate who was employed part time.<span>  </span>She did not smoke tobacco, drink alcohol, or use illicit drugs.<span>  </span>The screening psychiatric diagnostic interview (SCID) indicated that she had current dysthymic disorder, bulimia nervosa, and binge eating disorder, and a past diagnosis of depression.<span>  </span>At the time of initial evaluation she was in psychotherapy but not taking any prescription medications. </font></span></p>
<p style="margin:0in 19.05pt 0pt 37.05pt" class="MsoNormal"><span><font size="2" face="Arial">Ms. B began consuming caffeine regularly at age 18.<span>  </span>At the screening evaluation, her caffeinated beverages of choice were brewed coffee and green Japanese loose tea, both of which she prepared for herself at home.<span>  </span>She would typically have two large servings of coffee, and three medium servings of tea spaced throughout the morning.<span>  </span>Her average daily caffeine intake based on her baseline caffeine diaries was 702 mg/day.<span>  </span>She had made numerous attempts to quit over the past 23 years, having varied success lasting anywhere from 2 weeks to as long as 4 years. </font></span></p>
<p style="margin:0in 19.05pt 0pt 37.05pt" class="MsoNormal"><span><font size="2" face="Arial">Ms. B had been advised by her family doctor to reduce her caffeine consumption to help her heart palpitations, however she did not follow this advice because of strong cravings for coffee and tea, and because she believed that caffeine reduction would exacerbate her anxious and depressed mood.<span>  </span>Her husband also complained that her caffeine use adversely affected their relationship. </font></span></p>
<p style="margin:0in 19.05pt 0pt 37.05pt" class="MsoNormal"><span><font face="Arial"><font size="2">At the time of Ms. B’s counseling/treatment session her goal was to reduce her caffeine intake from 702 mg/day to about 150 mg/day, the equivalent of about one small coffee and one cup of tea each day.<span>  </span>She was able to reduce slightly (to about 600 mg/day by the second week), but reported that withdrawal symptoms prevented her from cutting back any further.<span>  </span>Throughout the 6 weeks of attempting to reduce, she reported various withdrawal symptoms including feeling more depressed, tired, angry, forgetful, difficulty concentrating, low motivation, increased appetite, and craving for caffeine.<span>  </span>At her 6-week follow up session she actually reported a slight increase to 720 mg/day.<span>  </span>At a 12-week follow up, she was able to reduce to 590 mg/day, at a 26-week follow up was back up to about 710 mg/day.<span>  </span>At the 6 month follow-up visit, she continued to use caffeine at levels (710 mg/day) similar to those at enrollment.<span>  </span>She reported that she was consuming enough caffeine to avoid withdrawal symptoms.<span>  </span></font></font></span></p>
<p style="margin:0in 19.05pt 0pt 37.05pt" class="MsoNormal"><span><font size="2" face="Arial">This case illustrates that a single one-hour counseling session is insufficient for some people to successful reduce their caffeine intake, despite being motivated to do so.<span>  </span>Ms. B may have had more success if a more gradual reduction plan was implemented and if additional follow-up support had been provided throughout her reduction attempt. </font></span></p>
<p style="margin:0in 19.05pt 0pt 37.05pt" class="MsoNormal"><span><font size="2" face="Arial"> </font></span></p>
<p style="text-indent:-37.05pt;margin:0in 19.05pt 0pt 48.45pt" class="MsoNormal"><b><span><font size="2" face="Arial">Case #3: </font></span></b></p>
<p style="margin:0in 19.05pt 0pt 37.05pt" class="MsoNormal"><span><font size="2" face="Arial">Mr. C, a 51-year-old single man, presented to a caffeine dependence treatment program with a chief complaint of sleep problems.<span>  </span>He was a high school graduate who was employed full time doing stock work overnight at a grocery store.<span>  </span>He enjoyed working the night shift and had done it for many years.<span>  </span>He did not smoke tobacco, drink alcohol, or use any illicit drugs.<span>  </span>Mr. C. had a slight heart murmur and arthritis, for which he took naproxen as needed. </font></span></p>
<p style="margin:0in 19.05pt 0pt 37.05pt" class="MsoNormal"><span><font size="2" face="Arial">Mr. C reported that he began regular use of caffeinated tea at age 8 and caffeinated soft drinks at age 12.<span>  </span>At the time of his screening interview, he reported consuming 2-liters per day of Diet Pepsi Max along with other diet soft drinks.<span>  </span>He said that the caffeine helped him stay awake through the night, but he consumed similar amounts of caffeine on his days off from work.<span>  </span>He attributed frequent urination and insomnia after his work shift to his caffeine consumption.<span>  </span>He had been advised by a doctor to cut back on his caffeine use to help with his sleeping problems.<span>  </span>He had attempted to do so but failed because he could not tolerate either the withdrawal headaches or the craving for his beverage of choice.<span>  </span>He reported having had made special trips to the store by bus, at 2:00 in the morning, because of strong cravings for soda. </font></span></p>
<p style="margin:0in 19.05pt 0pt 37.05pt" class="MsoNormal"><span><font size="2" face="Arial">The two week caffeine diary showed he was consuming approximately 496 mg of caffeine per day, from Diet Pepsi Max , Diet Pepsi, or Diet Coke.<span>  </span>Mr. C’s initial goal was to cut back his caffeine intake by about half.<span>  </span>Through participation in the caffeine dependence treatment program, Mr. C successfully eliminated all caffeine use.<span>  </span>Following a gradual caffeine reduction plan, he initially switched to Diet Coke or Diet Pepsi, which have less caffeine then Diet Pepsi Max.<span>  </span>He then began substituting caffeine free soda.<span>  </span>He surpassed his goal of reducing by half and eliminated caffeine altogether in 6 weeks of gradual reduction.<span>  </span>During the 6 week period of his reduction he reported occasional mild or severe headaches, cravings, and a drop in energy, but at the 6-month follow-up he continued to report no caffeine use and reported no withdrawal symptoms other than occasional cravings for caffeine beverages. </font></span></p>
<p class="MsoNormal"><span><font size="2" face="Arial"> </font></span></p>
<p class="MsoNormal"><span></span><b><span><font size="2" face="Arial">References</font></span></b><b><span><font size="2" face="Arial"> </font></span></b></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Alsene K, Deckert J, Sand P, et al. (2003) Association between A2a receptor gene polymorphisms and caffeine-induced anxiety<i>. </i><u>Neuropsychopharmacology</u> <u>28</u>:1694–1702. </font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">American Psychiatric Association (2000) <u>Diagnostic and Statistical Manual of Mental Disorders</u>, fourth edition, text revision. American Psychiatric Association, Washington D.C.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Beck JG, Berisford MA (1992) The effects of caffeine on panic patients: Response components of anxiety. <u>Behav Ther</u> <u>23</u>, 405-422.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Bernard ME, Dennehy S, Keefauver LW (1981) Behavioral treatment of excessive coffee and tea drinking: A case study and partial replication. <u>Behav Ther</u> <u>12</u>, 543–548.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Boulenger JP, Uhde TW, Wolff EA 3rd, et al. (1984) Increased sensitivity to caffeine in patients with panic disorders. Preliminary evidence. <u>Arch Gen Psychiatr</u> <u>41</u>(11), 1067–1071.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Borycz J, Pereira MF, Melani A, et al. (2007) Differential glutamate-dependent and glutamate-independent adenosine A(1) receptor-mediated modulation of dopamine release in different striatal compartments. <u>J Neurochem</u> <u>101</u>, 355-363</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Bruce M, Scott N, Shine P, et al. (1992) Anxiogenic effects of caffeine in patients with anxiety disorders. <u>Arch Gen Psychiatr</u> <u>49</u>(11), 867–869.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Charney DS, Heninger GR and Jatlow PI (1985) Increased anxiogenic effects of caffeine in panic disorders. <u>Arch Gen Psychiatry</u> <u>42</u>(3), 233-243. </font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Childs E, Hohoff C, Deckert J, et al. (2008) Association between ADORA2a and DRD2 polymorphisms and caffeine-induced anxiety<i>. </i><u>Neuropsychopharmacology</u> 33 (12), 2791-2800. </font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Crowley TJ, O’Brien C (2009) Workshop: Substance use disorders in DSM-V: A Progress Report. CPDD 71<sup>st</sup> Annual Scientific Meeting Program, pp. xi, College on Problems of Drug Dependence.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">De Freitas B, Schwartz G (1979) Effects of caffeine in chronic psychiatric patients. <u>Am J Psychiatr</u> <u>136</u>(10), 1337–1338.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Evans SM and Griffiths RR (1992) Caffeine tolerance and choice in humans. <u>Psychopharmacology</u> <u>108</u>(1–2), 51–59</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Ferré S (2008) An update on the mechanisms of the psychostimulant effects of caffeine. <u>Journal of Neurochemistry</u> <u>105</u>, 1067-1079 </font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Ferré S, Fredholm BB, Morelli M, et al. (1997) Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 20(10), 482-487</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=&quot;Fiore MC&quot;[Author]&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><span style="color:windowtext;text-decoration:none;text-underline:none"><font size="2" face="Arial">Fiore MC</font></span></a><font size="2" face="Arial">, </font><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=&quot;Novotny TE&quot;[Author]&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><span style="color:windowtext;text-decoration:none;text-underline:none"><font size="2" face="Arial">Novotny TE</font></span></a><font size="2" face="Arial">, </font><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=&quot;Pierce JP&quot;[Author]&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><span style="color:windowtext;text-decoration:none;text-underline:none"><font size="2" face="Arial">Pierce JP</font></span></a><font size="2" face="Arial">, </font><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=&quot;Giovino GA&quot;[Author]&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><span style="color:windowtext;text-decoration:none;text-underline:none"><font size="2" face="Arial">Giovino GA</font></span></a><font size="2" face="Arial">, </font><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=&quot;Hatziandreu EJ&quot;[Author]&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><span style="color:windowtext;text-decoration:none;text-underline:none"><font size="2" face="Arial">Hatziandreu EJ</font></span></a><font size="2" face="Arial">, </font><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=&quot;Newcomb PA&quot;[Author]&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><span style="color:windowtext;text-decoration:none;text-underline:none"><font size="2" face="Arial">Newcomb PA</font></span></a><font size="2" face="Arial">, </font><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=&quot;Surawicz TS&quot;[Author]&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><span style="color:windowtext;text-decoration:none;text-underline:none"><font size="2" face="Arial">Surawicz TS</font></span></a><font size="2" face="Arial">, </font><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=&quot;Davis RM&quot;[Author]&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><span style="color:windowtext;text-decoration:none;text-underline:none"><font size="2" face="Arial">Davis RM</font></span></a><font size="2" face="Arial">, Methods used to quite smoking in the United States. Do cessation programs help? <u>JAMA</u>, 263 (20): 2760-2765</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Foxx RM, Rubinoff A (1979) Behavioral treatment of caffeinism: Reducing excessive coffee drinking. <u>J Appl Behav Anal</u> <u>12</u>(3), 335–344.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Fredholm BB, Battig K, Holmen J, et al. (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51(1), 83–133</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Garrett BE, Griffiths RR (1998) Physical dependence increases the relative reinforcing effects of caffeine versus placebo. Psychopharmacology (Berl) <u>139</u>: 195-202</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Goldstein A, Kaizer S (1969) Psychotropic effects of caffeine in man. III. a questionnaire survey of coffee drinking and its effects in a group of housewives. <u>Clin Pharmacol Ther</u>, <u>10</u>: 477-488</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Goldstein A, Kaizer S, and Whitby O (1969) Psychotropic effects of caffeine in man. IV. Quantitative and qualitative differences associated with habituation to coffee. <u>Clin Pharmacol Ther</u> <u>10</u>(4), 489–497</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Greden JF, Fontaine P, Lubetsky M, et al. (1978) Anxiety and depression associated with caffeinism among psychiatric inpatients. <u>Am J Psychiatr</u> <u>135</u>(8), 963–966</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Griffiths RR, Bigelow GE, Liebson IA (1986) Human coffee drinking: reinforcing and physical dependence producing effects of caffeine. <u>J Pharmacol Exp Ther,</u> <u>239</u>: 416-425</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Griffiths RR, Juliano LM, and Chausmer AL (2003) Caffeine pharmacology and clinical effects. In <u>Principles of Addiction Medicine</u>, Third Edition (pp. 193-224), Graham AW, Schultz TK, Mayo-Smith MF, et al. (eds). American Society of Addictive Medicine, Chevy Chase, Maryland</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><font face="Arial"><font size="2"><span style="color:black">Griffiths, R.R., Ressig, C.J. (2008</span><span>) Substance abuse: Caffeine use disorders.<span>  </span>In A. Tasman, J. Kay, J. Lieberman, M. B. First, M Maj (Eds.) <u>Psychiatry, third edition, volume 1</u> (pp.1019-1040). <span style="color:black">Chichester</span>, UK:<span>  </span>John Wiley & Sons. </span></font></font></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Gurpegui M, Aguilar MC, Martinez-Ortega JM, et al. (2006) Fewer but heavier caffeine consumers in schizophrenia: a case-control study. <u>Schizophr Res</u> <u>86</u>(1-3), 276-283. </font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Hettema JM, Corey LA, and Kendler KS (1999) A multivariate genetic analysis of the use of tobacco, alcohol, and caffeine in a population based sample of male and female twins. <u>Drug Alcohol Depend</u> <u>57</u>(1), 69–78.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Hughes JR (1994) Caffeine withdrawal, dependence, and abuse. In American Psychiatric Association: <u>Diagnostic and Statistical Manual of Mental Disorders, fourth edition</u>. American Psychiatric Association, Washington D.C., pp 129-134</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Hughes JR, Amori G, Hatsukami DK (1988) A survey of physician advice about caffeine. <u>J Subst Abuse</u> <u>1</u>(1), 67–70</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Hughes JR, McHugh P, Holtzman S. (1998a) Caffeine and schizophrenia. <u>Psychiatric Services</u>, <u>49</u>, 1415-1417</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Hughes JR, Oliveto AH, Bickel WK, Higgins ST, Badger GJ (1993) Caffeine self-administration and withdrawal: incidence, individual differences and interrelationships. <u>Drug Alcohol Depend</u> <u>32</u>: 239-246</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Hughes JR, Oliveto AH, MacLaughlin M (2000) Is dependence on one drug associated with dependence on other drugs? The cases of alcohol, caffeine and nicotine. <u>Am J Addict</u> <u>9</u>(3), 196–201</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Hughes JR, Oliveto AH, Helzer JE, Higgins ST, Bickel WK<span>  </span>(1992) </font><a href="http://www.ncbi.nlm.nih.gov/pubmed/1728182?ordinalpos=27&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum"><u style="text-underline:#1300c6"><span style="color:windowtext;text-decoration:none;text-underline:none"><font size="2" face="Arial">Should caffeine abuse, dependence, or withdrawal be added to DSM-IV and ICD-10?</font></span></u></a><font size="2" face="Arial"> <u>Am J Psychiatry</u>, <u>149</u>:33-40</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Hughes JR, Oliveto AH, Liguori A, Carpenter J, Howard T (1998b) Endorsement of DSM-IV dependence criteria among caffeine users. <u>Drug Alcohol Depend</u>, <u>52</u>: 99-107</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">James JE, Paull I, Cameron-Traub E, et al. (1988) Biochemical validation of self-reported caffeine consumption during caffeine fading. <u>J Behav Med</u> <u>11</u>(1), 15–30. </font></span></p>
<p style="text-indent:-16.05pt;margin:0in -19.05pt 0pt 17.1pt" class="MsoNormal"><span><font size="2" face="Arial">James JE, Stirling KP, and Hampton BAM (1985) Caffeine fading: Behavioral treatment of caffeine abuse. <u>Behav Ther</u> <u>16</u>, 15–27.</font></span></p>
<p style="text-indent:-16.05pt;margin:0in -19.05pt 0pt 17.1pt" class="MsoNormal"><span></span><font size="2" face="Arial"> </font></p>
<p style="text-indent:-16.05pt;margin:0in -19.05pt 0pt 17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Jones HA , Lejuez CW (2005) Personality correlates of caffeine dependence: the role of sensation seeking, impulsivity, and risk taking. <u>Exp Clin Psychopharmacol</u> <u>13</u>(3): 259-266 </font></span></p>
<p style="text-indent:-16.05pt;margin:0in -19.05pt 0pt 17.1pt" class="MsoNormal"><span></span><font size="2" face="Arial"> </font></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Juliano, L.M., Ferré, S., & Griffiths, R.R. (in press) Caffeine: pharmacology and clinical effects.<span>  </span>In R. Ries, Fiellin, D., Miller, S., & Saitz, R. (Eds.)<span>  </span>Principles of Addiction Medicine, Fourth Edition (pp.).<span>  </span>Baltimore: Lippincott Williams & Wilkins.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Juliano, LM, Griffiths, RR<span>  </span>(2004) A critical review of caffeine withdrawal: Empirical validation of symptoms and signs, incidence, severity, and associated features. <u>Psychopharmacology</u>, <u>176</u>: 1-29 </font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Juliano, LM & Griffiths, R.R. (2009, in press) Caffeine-related disorders.<span>  </span>In B.J. Sadock, V.A. Sadock, & P. Ruiz (Eds.) <u>Comprehensive Textbook of Psychiatry </u>(pp.). Ninth Edition. Philadelpia:<span>  </span>Lippincott Williams & Wilkins. </font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Kleber, HD, Weiss, RD, et al. (2007) Treatment of patients with substance use disorders, second edition, American Psychiatric Association Practice Guidelines. American Journal of Psychiatry, 164 (4), 1-123.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Kendler KS, Myers J, Prescott CA. (2007) Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence<i>.</i> <u>Arch Gen Psychiatry</u>, <u>64</u>:1313-1320.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Kendler KS, Prescott CA (1999) Caffeine intake, tolerance, and withdrawal in women: A population-based twin study. <u>Am J Psychiatr</u> <u>156</u>(2), 223–228.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Kendler KS, Schmitt E, Aggen SH, Precott CA. (2008) Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood. <u>Arch Gen Psychiatry</u>, <u>65</u>, 674-682</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Lee MA, Cameron OG, Greden JF (1985) Anxiety and caffeine consumption in people with anxiety disorders. <u>Psychiatr Res</u> <u>15</u>(3), 211–217</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Liguori A,Hughes JR. (1997) Caffeine self-administration in humans: 2. A within-subjects comparison of coffee and cola vehicles<i>.</i> <u>Exp Clin Psychopharmacol</u>. <u>5</u>: 295-303</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Martin CS, Chang T, Langenbucher JW (2008) How should we revise diagnostic criteria for substance use disorders in the DSM-V? <u>J Abn Psychol</u> <u>117</u>, 561-575</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Mikkelsen EJ (1978) Caffeine and schizophrenia. <u>J Clin Psychiatr</u> <u>39</u>(9), 732–736.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><font face="Arial"><font size="2"><span>Miyata H, Hironaka N, Takada K, Miyasato K, Nakamura K, Yanagita T. Psychosocial withdrawal characteristics of nicotine compared with alcohol and caffeine. </span><u><span lang="ES">Ann N Y Acad Sci</span></u><span lang="ES">. <u>1139</u>: 458-465.</span></font></font></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><font face="Arial"><font size="2"><span lang="ES">Nardi AE, Valenca AM, Nascimento I, et al. </span><span>A caffeine challenge test in panic disorder patients, their healthy first-degree relatives, and healthy controls. <u>Depress Anxiety</u> <u>25</u>(10) 847-853.2007. </span></font></font></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Oberstar JV, Bernstein GA, Thuras PD (2002) Caffeine use and dependence in adolescents: one-year follow-up. <u>J Child Adolesc Psychopharmacol</u>, <u>12</u>: 127-135</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Ogawa, N. Ueki, H.<span>  </span>(2007) Clinical importance of caffeine dependence and abuse. <u>Psychiatry Clin Neurosci</u>, <u>61</u>: 263-268</font></span></p>
<p style="text-indent:-16.05pt;margin:0in -19.05pt 0pt 17.1pt" class="MsoBodyTextIndent"><span><font size="2" face="Arial">Partanen J, Bruun K, and Markkenen T (1966) Inheritance of Drinking Behavior: A Study of Intelligence, Personality, and Use of Alcohol in Adult Twins. The Finnish Foundation for Alcohol Studies, Helsinki.</font></span></p>
<p style="text-indent:-16.05pt;margin:0in -19.05pt 0pt 17.1pt" class="MsoBodyTextIndent"><span></span><font size="2" face="Arial"> </font></p>
<p style="text-indent:-16.05pt;margin:0in -19.05pt 0pt 17.1pt" class="MsoBodyTextIndent"><span><font size="2" face="Arial">Pedersen N (1981) Twin similarity for usage of common drugs. In <u>Twin Research 3. Part C: Epidemiological and Clinical Studies</u>, Gedda L, Parisi P, and Nance W (eds). Alan R. Liss, New York, pp. 53–59.</font></span></p>
<p style="text-indent:-16.05pt;margin:0in -19.05pt 0pt 17.1pt" class="MsoBodyTextIndent"><span></span><font size="2" face="Arial"> </font></p>
<p style="text-indent:-16.05pt;margin:0in -19.05pt 0pt 17.1pt" class="MsoBodyTextIndent"><span><font size="2" face="Arial">Richards BD, Juliano LM, and Griffiths RR (2004) Characterization of individuals seeking treatment for caffeine dependence. <u>Abstracts of the 66<sup>th</sup> Annual Meeting of the College on Problems of Drug Dependence</u> 155. [data shown are from updated report in preparation, N=74]</font></span></p>
<p style="text-indent:-16.05pt;margin:0in -19.05pt 0pt 17.1pt" class="MsoBodyTextIndent"><span><span style="letter-spacing:-0.15pt"></span></span><font size="2" face="Arial"> </font></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><font face="Arial"><font size="2"><span>Quarta D, Borycz J, Solinas M, et al. (2004a) Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation. </span><span lang="ES">J Neurochem 91(4), 873-880</span></font></font></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><font face="Arial"><font size="2"><span lang="ES">Quarta D, Ferre S, Solinas M, et al. </span><span>(2004b) Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure. J Neurochem 88(5), 1151-1158</span></font></font></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Rihs M, Muller C, and Baumann P (1996) Caffeine consumption in hospitalized psychiatric patients. <u>Eur Arch Psychiatr Clin Neurosci</u> <u>246</u>(2), 83–92.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Rogers PJ, Richardson NJ, Elliman NA (1995) Overnight caffeine abstinence and negative reinforcement of preference for caffeine-containing drinks. <u>Psychopharmacology (Berl)</u> <u>120</u>: 457-462</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Satel, S.<span>  </span>(2006) Is caffeine addictive?—a review of the literature. <u>Am J Drug Alcohol Abuse</u>, <u>32</u>: 493-502</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Schuh KJ, Griffiths RR (1997) Caffeine reinforcement: the role of withdrawal. <u>Psychopharmacology (Berl)</u> <u>130</u>: 320-326</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Sobell LC, Ellingstad TP, Sobell MB (2000) Natural recovery from alcohol and drug problems: methodological review of the research with suggestions for future directions. <u>Addiction</u> <u>95</u>:749-764</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Solinas M, Ferre S, You ZB, et al. (2002) Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci 22(15), 6321-6324</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Strain EC, Mumford GK, Silverman K, Griffiths RR (1994) Caffeine dependence syndrome. evidence from case histories and experimental evaluations. <u>JAMA</u>, <u>272</u>: 1043-1048</font></span></p>
<p style="text-indent:-16.05pt;margin:0in -19.05pt 0pt 17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Strassnig M, Brar JS, and Ganguli R (2006) Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia. <u>Schizophr Res</u> <u>86</u>(1-3), 269-275. </font></span></p>
<p style="text-indent:-16.05pt;margin:0in -19.05pt 0pt 17.1pt" class="MsoNormal"><span></span><font size="2" face="Arial"> </font></p>
<p style="text-indent:-16.05pt;margin:0in -19.05pt 0pt 17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Striley CLW, Cottler LB, (2007) <span>Adopting DSM-IV dependence criteria for caffeine: DSM-V implications</span>, paper presented at Symposium Caffeine as a gateway to addiction, College on Problems of Drug Dependence annual meeting, Quebec City, Canada, June 20, 2007. </font></span></p>
<p style="text-indent:-16.05pt;margin:0in -19.05pt 0pt 17.1pt" class="MsoNormal"><span></span><font size="2" face="Arial"> </font></p>
<p style="text-indent:-16.05pt;margin:0in -19.05pt 0pt 17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Svikis DS, Berger N, Haug NA, Griffiths RR, (2005) Caffeine dependence in combination with a family history of alcoholism as a predictor of continued use of caffeine during pregnancy. <u>Am J Psychiatry</u><i>.</i> <u>162</u>(12): 2344-2351 </font></span></p>
<p style="text-indent:-16.05pt;margin:0in -19.05pt 0pt 17.1pt" class="MsoNormal"><span></span><font size="2" face="Arial"> </font></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Swan GE, Carmelli D, and Cardon LR (1997) Heavy consumption of cigarettes, alcohol and coffee in male twins. <u>J Stud Alcohol</u> <u>58</u>(2), 182–190.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Tinley EM, Yeomans MR, Durlach PJ (2003) Caffeine reinforces flavour preference in caffeine-dependent, but not long-term withdrawn, caffeine consumers. <u>Psychopharmacology (Berl)</u> <u>166</u>: 416-423</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Tondo L and Rudas N (1991) The course of a seasonal bipolar disorder influenced by caffeine. <u>J Affect Disord</u> <u>22</u>(4), 249–251.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Uhde TW (1990) Caffeine provocation of panic: A focus on biological mechanisms. In <u>Neurobiology of Panic Disorder</u>, Ballenger JC (ed). Alan R. Liss, New York, pp. 219–242.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Winstead DK (1976) Coffee consumption among psychiatric inpatients. <u>Am J Psychiatr</u> <u>133</u>(12), 1447–1450.</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">World Health Organization (1992a) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">World Health Organization (1992b) International statistical classification of diseases and related health problems, 10th revision. World Health Organization, Geneva</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Yeomans MR, Jackson A, Lee MD, Nesic J, Durlach PJ (2000) Expression of flavour preferences conditioned by caffeine is dependent on caffeine deprivation state. <u>Psychopharmacology (Berl)</u> <u>150</u>: 208-215</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Yeomans MR, Pryke R, Durlach PJ (2002) Effect of caffeine-deprivation on liking for a non-caffeinated drink. <u>Appetite</u> <u>39</u>: 35-42</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Yeomans MR, Ripley T, Lee MD, Durlach PJ (2001) No evidence for latent learning of liking for flavours conditioned by caffeine. <u>Psychopharmacology (Berl)</u> <u>157</u>: 172-179</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Yeomans MR, Spetch H, Rogers PJ (1998) Conditioned flavour preference negatively reinforced by caffeine in human volunteers. <u>Psychopharmacology (Berl)</u> <u>137</u>: 401-409</font></span></p>
<p style="text-indent:-16.05pt;margin-left:17.1pt" class="MsoNormal"><span><font size="2" face="Arial">Zaslove MO, Russell RL, and Ross E (1991) Effect of caffeine intake on psychotic in-patients. <u>Br J Psychiatr</u> <u>159</u>, 565–567.</font></span></p></div><div id="DSM_TabContent_Severity"><div style="display:inline" id="ctl00_m_g_f7094959_4272_49f5_a3fd_5fec8167517e_ctl00_ctl04_ctl04_ctl00_ctl00_ctl05_ctl00__ControlWrapper_RichHtmlField">
<div style="display:inline"><span style="line-height:200%;font-family:'arial','sans-serif';font-size:10pt">
<div style="display:block" align="right">
<div style="display:inline"><span style="font-family:'arial','sans-serif';font-size:10pt"><em>Updated May 1, 2012</em></span></div></div>
<div style="display:block">
<div style="display:inline"><span style="font-family:'arial','sans-serif';font-size:10pt"><strong><u>Severity Scale:</u></strong></span> </div>
<p style="line-height:200%;display:block" class="MsoNormal"><span style="line-height:200%;font-family:'arial','sans-serif';font-size:10pt">The Severity of each Substance Use Disorder is based on: </span></p>
<p style="line-height:200%;text-indent:-0.25in;display:block;margin-left:0.5in" class="MsoNormal"><span style="line-height:200%;font-family:symbol;font-size:10pt" lang="ES"><span>-<span style="font:7pt 'times new roman'"> </span></span></span><span style="line-height:200%;font-family:'arial','sans-serif';font-size:10pt" lang="ES">0 criteria or 1 criterion: No diagnosis</span></p>
<p style="line-height:200%;text-indent:-0.25in;display:block;margin-left:0.5in" class="MsoNormal"><span style="line-height:200%;font-family:symbol;font-size:10pt"><span>-<span style="font:7pt 'times new roman'"> </span></span></span><span style="line-height:200%;font-family:'arial','sans-serif';font-size:10pt">2-3 criteria: Mild Substance Use Disorder</span></p>
<p style="line-height:200%;text-indent:-0.25in;display:block;margin-left:0.5in" class="MsoNormal"><span style="line-height:200%;font-family:symbol;font-size:10pt"><span>-<span style="font:7pt 'times new roman'"> </span></span></span><span style="line-height:200%;font-family:'arial','sans-serif';font-size:10pt">4-5 criteria: Moderate Substance Use Disorder</span></p>
<p style="line-height:200%;text-indent:-0.25in;display:block;margin-left:0.5in" class="MsoNormal"><span style="line-height:200%;font-family:symbol;font-size:10pt"><span>-<span style="font:7pt 'times new roman'"> </span></span></span><span style="line-height:200%;font-family:'arial','sans-serif';font-size:10pt">6 or more criteria: Severe Substance Use Disorder</span></p>
<p style="display:block" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt"></span></b></p></div>
<p style="display:block"></p>
<p style="display:block">
<div style="display:inline"><font size="2" face="Arial"><strong><u></u></strong></font></div>
<p style="display:block"></p>
<p style="display:block">
<div style="display:block">
<div style="display:inline"><font size="2" face="Arial"><strong><u>Rationale for the proposed Severity Measure:</u></strong></font> </div>
<p style="display:block"></p>
<p style="display:block;margin-left:0.25in" class="MsoNormal"><font face="Arial"><font size="2"><span><font color="#000000">Three measures of alcohol use disorder severity were assessed in relation to several external valuators (various measures of consumption, family history, major depression and antisocial personality disorder): (1) simple counts of substance use disorder criteria; (2) count of diagnostic criteria with each criterion weighted by its relative severity derived from item response theory analysis; and (3) count of diagnostic criteria each weighted by its frequency of occurrence (Dawson et al. in press). The results show that un-weighted symptom counts of the diagnostic criteria appeared equally effective, less time consuming, and similarly associated with external correlates of the disorder, as the later two scalar measure of alcohol use disorders. Using a different analytic strategy, early onset of drinking and family history of alcohol problems in parents or siblings produced a similar result (Hasin and Beseler, 2009).</font></span><span><font color="#000000"> </font></span></font></font></p>
<p style="display:block;margin-left:0.25in" class="MsoNormal"><font face="Arial"><font size="2"><span><font color="#000000">Among adolescents, 2 or 3 criteria identify a group with severity of alcohol use disorder very close to that of adolescents with DSM-IV alcohol abuse, while 4 or more criteria identify a group with severity very close to that of DSM-IV dependence. Using criterion counts results in much more homogeneous groups than DSM-IV’s abuse and dependence groups (Gelhorn et al., 2008).</font></span><span><font color="#000000"> </font></span></font></font></p>
<p style="display:block;margin-left:0.25in" class="MsoNormal"><font face="Arial"><font size="2"><span style="color:red"><font color="#000000">The cutoffs of 2 or more criteria for a substance use diagnosis, with 2 or 3 criteria reflecting moderate severity and 4 or more criteria reflecting severe severity of a substance use disorder were empirically determined using several databases including the NESARC, COGA, large emergency room studies conducted in several countries, and a clinical study. Kappa statistics and Receiver Operating Characteristic analyses were calculated to identify the proposed cut-points associated with the greatest sensitivity and specificity across drug classes. The proposed cutoff points have been shown to yield similar prevalence and high concordance in relation to the combined DSM-IV substance abuse and dependence diagnoses.</font></span><span><font color="#000000"> </font></span></font></font><span><font color="#000000"><font size="2" face="Arial"></font></font></span></p>
<p style="display:block;margin-left:0.25in" class="MsoNormal"><span><font color="#000000"><span><font size="2" face="Arial">Although counts of criteria-met provide a useful measure of differences in severity-of-disorder among different individuals, there is not strong evidence showing that criterion counts usefully measure change in severity in one person over relatively brief periods of a few days, weeks, or months. Measures of such shorter-term changes are needed, e.g., to assess whether a treatment is improving the severity of a patient’s disorder. For that purpose an extensive clinical-trials literature (for example, Anton et al., 2006; Crits-Christoph et al., 1999; O’Malley et al., 2007) has relied on three measures obtained at intake and follow-up: (a) self-report of frequency of use (number of days patient used the substance, e.g., in the last week, or the last month), (b) when possible, similar reports from another closely-involved observer (e.g., a spouse), and (c) <span></span>tests for the substance or substance-related biological products in appropriately-timed samples of urine, blood, saliva, breath, or hair (such tests may disconfirm false-negative reports and encourage valid reporting). The Substance-Related Disorders Workgroup recommends those three procedures as measures of within-subject, across-time, changes in severity of substance use disorder over periods of a few days, weeks, or months</font></span></p></font></span>
<p style="text-align:justify;text-indent:-0.25in;display:block;margin-left:0.5in" class="MsoBodyText2"><span><font color="#000000" size="2" face="Arial">Anton RF, O’Malley SS, Ciraulo DA, Cisler RA, Couper D,Donovan DM, et al. 2006. Combined pharmacotherapies and behavioral interventions for alcohol dependence. JAMA 295, 2003-2017.</font></span></p>
<p style="text-align:justify;text-indent:-0.25in;display:block;margin-left:0.5in" class="MsoBodyText2"><span><font color="#000000" size="2" face="Arial">Crits-Christoph P, Siqueland L, Blaine J, Frank A, Luborskky L, onken LS, Muenz LR, et al. 1999. Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch. Gen. Psychiatry 56, 493-502.</font></span></p>
<p style="text-align:justify;text-indent:-0.25in;display:block;margin-left:0.5in" class="MsoBodyText2"><span><font color="#000000" size="2" face="Arial">Dawson, D.A., Grant B.F. Submitted. Should symptom frequency be factored into scalar measures of alcohol use disorder severity? Addiction.</font></span></p>
<p style="text-indent:-0.25in;display:block;margin-left:0.5in" class="MsoBodyText2"><span><font color="#000000" size="2" face="Arial">Dawson, D.A., Saha, T.D., Grant, B.F. In press. A multidimensional assessment of the validity and utility of alcohol use disorder severity as determined by item response theory models. Drug Alcohol Dependence.</font></span></p>
<p style="text-indent:-0.25in;display:block;margin-left:0.5in" class="MsoNormal"><span><font color="#000000" size="2" face="Arial">Gelhorn H, Hartman C, Sakai J, Stallings M, Young S, Rhee SH, Corley R, Hewitt J, Hopfer C, Crowley T. 2008. Toward DSM-V: an Item Response Theory analysis of the diagnostic process for alcohol abuse and dependence in DSM-IV. J. Amer. Acad. Child Adol. Psychiatry 47, 1329-1339.</font></span></p>
<p style="text-indent:-0.25in;display:block;margin-left:0.5in" class="MsoBodyText2"><span><font color="#000000" size="2" face="Arial">Hasin DS, Beseler CL. 2009. Dimensionality of lifetime alcohol abuse, dependence and binge drinking. Drug Alcohol Depend. 101, 53-61.</font></span></p>
<p style="text-indent:-0.25in;display:block;margin-left:0.5in" class="MsoBodyText2"><span><font color="#000000" size="2" face="Arial">O’Malley SS, Garbutt JC, Gastfriend DR, Dong Q, Kranzler HR. 2007. Efficacy of extended release naltrexone in alcohol-dependent patients who are abstinent before treatment J. Clin Psychopharmacoloogy 27, 507-512.</font></span></p></div></span></div></div></div><div id="DSM_TabContent_DSM-IV"><font face="Arial"><font size="2"><span>
<div style="display:block" id="DSM_TabContent_DSM-IV"><span style="font-family:'arial', 'sans-serif';font-size:8pt"><span style="font-family:'arial', 'sans-serif';font-size:10pt">This disorder is not listed in DSM-IV; therefore, DSM-IV criteria for this disorder do not exist.</span></span></div></span></font></font></div></td></tr></table></td></tr></table><table cellspacing="0" cellpadding="4" border="0" width="100%" xmlns:x="http://www.w3.org/2001/XMLSchema" xmlns:d="http://schemas.microsoft.com/sharepoint/dsp" xmlns:asp="http://schemas.microsoft.com/ASPNET/20" xmlns:__designer="http://schemas.microsoft.com/WebParts/v2/DataView/designer" xmlns:sharepoint="Microsoft.SharePoint.WebControls" xmlns:ddwrt2="urn:frontpage:internal"><tr></tr></table></div></td>
			</tr>
		</table></td>
	</tr>
</table>
	</div>
	<div id="DSM_RightCol">
		<div id="DSM_int_topRight">	
			<table width="100%" cellpadding="0" cellspacing="0" border="0">
	<tr>
		<td id="MSOZoneCell_WebPartWPQ3" valign="top"><table toplevel border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td valign="top"><div webpartid="29710d0b-d267-4d1e-8295-7591f28eec41" haspers="false" id="WebPartWPQ3" width="100%" class="ms-WPBody" allowdelete="false" style=""><div id="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41">
        <table id="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1" cellspacing="0" cellpadding="0" border="0">
						<tr>
							<td>
                <table border="0" cellpadding="1" cellspacing="0" style="border-collapse: collapse">
                    <tr>
                        <td>
                            <table border="0" cellpadding="0">
                                <tr valign="top">
                                    <td align="left" colspan="2" valign="top">
                                        <h2>Participate</h2><!--Login to comment on the DSM-5-->
                                    </td>
                                </tr>
                                <tr valign="top">
                                    <td align="right">
                                        <label for="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1_UserName" id="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1_UserNameLabel">User Name:</label></td>
                                    <td>
                                        <input name="ctl00$m$g_29710d0b_d267_4d1e_8295_7591f28eec41$ctl00$LoginView1$Login1$UserName" type="text" id="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1_UserName"/>
                                    </td>
                                </tr>
                                <tr valign="top">
                                    <td align="right">
                                        <label for="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1_Password" id="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1_PasswordLabel">Password:</label></td>
                                    <td>
                                        <input name="ctl00$m$g_29710d0b_d267_4d1e_8295_7591f28eec41$ctl00$LoginView1$Login1$Password" type="password" id="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1_Password"/>                                        
                                    </td>
                                </tr>
                                <tr valign="top">
                                    <td></td>                                
                                    <td align="left">
                                        <input type="submit" name="ctl00$m$g_29710d0b_d267_4d1e_8295_7591f28eec41$ctl00$LoginView1$Login1$LoginButton" value="Login" id="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1_LoginButton"/>
                                    </td>
                                    <td></td>
                                </tr>
                                <tr valign="top" align="left">
                                    <td align="center" colspan="2" style="color: red">
                                    </td>
                                </tr>
                                <tr align="left">
                                    <td align="left" colspan="2">                                        
    <a id="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1_hlRegistration" href="../../Pages/Registration.html">
      New User? Register Now
    </a>
                                    </td>
                                </tr>
                                <tr align="left">
                                    <td align="left" colspan="2">                                        
    <a id="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1_hlForgotPassword" href="../../Pages/ForgotPassword.html">
      Forgot Password?
    </a>
                                    </td>
                                </tr>
                            </table>
                        </td>
                    </tr>
                </table>
            </td>
						</tr>
					</table>
				</div></div></td>
			</tr>
		</table></td>
	</tr>
</table>	
		</div>
		<div id="DSM_int_btmRight">
			<div id="ctl00_PlaceHolderMain_ctl00__ControlWrapper_RichHtmlField" style="display:inline"></div>						
			<table width="100%" cellpadding="0" cellspacing="0" border="0">
	<tr>
		<td id="MSOZoneCell_WebPartWPQ1" valign="top"><table toplevel border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td valign="top"><div webpartid="8bd325df-1ef5-4c59-9cf9-133a68ebd1c0" haspers="false" id="WebPartWPQ1" width="100%" allowdelete="false" allowexport="false" style=""><table width="100%" cellspacing="0" cellpadding="0" border="0"><script>
ctx = new ContextInfo();
ctx.listBaseType = 0;
ctx.listTemplate = 103;
ctx.listName = "{B800DB4C-1750-45F8-87A7-8DC7A15C16A1}";
ctx.view = "{8BD325DF-1EF5-4C59-9CF9-133A68EBD1C0}";
ctx.listUrlDir = "\u002fProposedRevisions\u002fLists\u002fRelated\u002520Links";
ctx.HttpPath = "\u002fProposedRevisions\u002f_vti_bin\u002fowssvr.dll?CS=65001";
ctx.HttpRoot = "https:\u002f\u002f\u002fweb\u002f20121019203601\u002fhttp:\u002f\u002fwww.dsm5.org\u002fProposedRevisions";
ctx.imagesPath = "\u002f_layouts\u002fimages\u002f";
ctx.PortalUrl = "";
ctx.SendToLocationName = "";
ctx.SendToLocationUrl = "";
ctx.RecycleBinEnabled = -1;
ctx.OfficialFileName = "";
ctx.WriteSecurity = "1";
ctx.SiteTitle = "Proposed Revisions";
ctx.ListTitle = "Proposed Revisions Related Links";
if (ctx.PortalUrl == "") ctx.PortalUrl = null;
ctx.displayFormUrl = "\u002fProposedRevisions\u002fLists\u002fRelated\u002520Links\u002fDispForm.aspx";
ctx.editFormUrl = "\u002fProposedRevisions\u002fLists\u002fRelated\u002520Links\u002fEditForm.aspx";
ctx.isWebEditorPreview = 0;
ctx.ctxId = 1;
g_ViewIdToViewCounterMap[ "{8BD325DF-1EF5-4C59-9CF9-133A68EBD1C0}" ]= 1;
ctx.CurrentUserId = -1;
ctx1 = ctx;
</script><tr><td><table id="{B800DB4C-1750-45F8-87A7-8DC7A15C16A1}-{8BD325DF-1EF5-4C59-9CF9-133A68EBD1C0}" summary="Proposed Revisions Related Links" o:webquerysourcehref="http://www.dsm5.org/ProposedRevisions/_vti_bin/owssvr.dll?CS=65001&amp;XMLDATA=1&amp;RowLimit=0&amp;List={B800DB4C-1750-45F8-87A7-8DC7A15C16A1}&amp;View={8BD325DF-1EF5-4C59-9CF9-133A68EBD1C0}" class="ms-summarycustombody" style="margin-bottom: 5px;" cellpadding="0" cellspacing="0" border="0">
                        <tr>
                            <td style="padding-bottom: 5px" class="ms-vb"><img src="../../_layouts/images/square.gif" alt="">&nbsp;</td>
                            <td style="padding-bottom: 5px;padding-left: 5px;" class="ms-vb">
                        <a onfocus="OnLink(this)" href="http://www.psych.org/">American Psychiatric Association</a>
                            </td>
                        </tr>
                    </table></td></tr></table><table id="ECBItems" style="display:none" height="0" width="0"><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/ProposedRevisions/_layouts/formserver.aspx?XsnLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xsn</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/ProposedRevisions/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/ProposedRevisions/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document.2</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/ProposedRevisions/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document.3</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/ProposedRevisions/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document.4</td><td>255</td></tr><tr><td>View in Web Browser</td><td>/_layouts/images/ichtmxls.gif</td><td>/ProposedRevisions/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&DefaultItemOpen;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsx</td><td>255</td></tr><tr><td>View in Web Browser</td><td>/_layouts/images/ichtmxls.gif</td><td>/ProposedRevisions/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&DefaultItemOpen;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsb</td><td>255</td></tr><tr><td>Snapshot in Excel</td><td>/_layouts/images/ewr134.gif</td><td>/ProposedRevisions/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&Snapshot;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsx</td><td>256</td></tr><tr><td>Snapshot in Excel</td><td>/_layouts/images/ewr134.gif</td><td>/ProposedRevisions/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&Snapshot;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsb</td><td>256</td></tr></table></div></td>
			</tr>
		</table></td>
	</tr>
</table>						
		</div>						
	</div>	
	<div class="DSM_clear"><img src="../../Style Library/DSM_Images/clear.gif" width="1" height="1" alt=""/></div>	
<!---- end MAIN CONTENT AREA ---->
			</div>
			<div id="DSM_Footer">
				<p class="DSM_Tagline">Representing 36,000 physician leaders in mental health.</p>
				<p>© <strong>2012 American Psychiatric Association.</strong> All Rights Reserved.<br/>
				Use of all Materials on this Website is subject to the <a href="../../Pages/PermissionsPolicy.html">APA Permissions Policy</a> and <a href="../../Pages/TermsandConditionsofUse.html">Terms and Conditions of Use.</a><br/>
				<br/>  
				1000 Wilson Boulevard, Suite 1825, Arlington, Va. 22209-3901<br/>
				phone: 703-907-7300 <a href="mailto:apa@psych.org?subject=DSM5:">email: apa@psych.org</a></p>
				<div class="DSM_SocialLinks">
	 				<table>
	 					<tr>
	 						<td>Find us on:</td>
							<td><a href="http://www.facebook.com/pages/DSM-5-Diagnostic-and-Statistical-Manual-of-Mental-Disorders/260197062886" target="_blank"><img src="../../Style Library/DSM_Images/facebook.gif" width="58" height="15" alt="Find us on Facebook"/></a></td>
							<td><a href="http://twitter.com/dsm5" target="_blank"><img src="../../Style Library/DSM_Images/twitter.jpg" width="60" height="20" alt="Find us on Twitter"/></a></td>
						</tr>
	 				</table>
				</div>
				<p><a href="../../pages/Contactus.html">Contact Us For Help</a></p>
			</div>		
		</div>
<!-- end MAIN LAYOUT -->
<!-- begin EDITOR POSITIONING DIV -->
	<div id="ctl00_MSO_ContentDiv" class="SP_editorPosition">&nbsp;</div>
<!-- end EDITOR POSITIONING DIV -->
<!-- begin HIDDEN MASTER PAGE ELEMENTS -->
	<div style="display:none">
			<div class="breadcrumb">
				<span id="ctl00_PlaceHolderTitleBreadcrumb_siteMapPath"><a href="#ctl00_PlaceHolderTitleBreadcrumb_siteMapPath_SkipLink"><img alt="Skip Navigation Links" height="0" width="0" src="../../WebResource.axd_d_nmHMzpcb8opA4_TBGiLLxg2_t_633965588901821931.jpg" border="0"/></a><span><a class="ms-sitemapdirectional" href="/">Home</a></span><span> &gt; </span><span><a title="Proposed Revisions" class="ms-sitemapdirectional" href="../../ProposedRevisions/Pages/Default.html">Proposed Revisions</a></span><span> &gt; </span><span class="breadcrumbCurrent">Proposed Revision</span><a id="ctl00_PlaceHolderTitleBreadcrumb_siteMapPath_SkipLink"></a></span>
			</div>
	</div>
<!-- end HIDDEN MASTER PAGE ELEMENTS -->
<script type="text/javascript">
//<![CDATA[
var __wpmExportWarning='This Web Part Page has been personalized. As a result, one or more Web Part properties may contain confidential information. Make sure the properties contain information that is safe for others to read. After exporting this Web Part, view properties in the Web Part description file (.WebPart) by using a text editor such as Microsoft Notepad.';var __wpmCloseProviderWarning='You are about to close this Web Part.  It is currently providing data to other Web Parts, and these connections will be deleted if this Web Part is closed.  To close this Web Part, click OK.  To keep this Web Part, click Cancel.';var __wpmDeleteWarning='You are about to permanently delete this Web Part.  Are you sure you want to do this?  To delete this Web Part, click OK.  To keep this Web Part, click Cancel.';var zz1_TopNavigationMenu_Data = new Object();
zz1_TopNavigationMenu_Data.disappearAfter = 500;
zz1_TopNavigationMenu_Data.horizontalOffset = 0;
zz1_TopNavigationMenu_Data.verticalOffset = 0;
zz1_TopNavigationMenu_Data.hoverClass = 'zz1_TopNavigationMenu_15 DSM_dynamicNavHover';
zz1_TopNavigationMenu_Data.hoverHyperLinkClass = 'zz1_TopNavigationMenu_14 DSM_dynamicNavHover';
zz1_TopNavigationMenu_Data.staticHoverClass = 'zz1_TopNavigationMenu_13 DSM_staticNavHover';
zz1_TopNavigationMenu_Data.staticHoverHyperLinkClass = 'zz1_TopNavigationMenu_12 DSM_staticNavHover';
if (typeof(overrideMenu_HoverStatic) == 'function' && typeof(Menu_HoverStatic) == 'function')
{
_spBodyOnLoadFunctionNames.push('enableFlyoutsAfterDelay');
Menu_HoverStatic = overrideMenu_HoverStatic;
}
var flyoutsAllowed = false;
function enableFlyoutsAfterDelay()
{
setTimeout('flyoutsAllowed = true;', 50);
}
function overrideMenu_HoverStatic(item)
{
if (!flyoutsAllowed || (document.readyState != null && document.readyState != 'complete'))
{
setTimeout(delayMenu_HoverStatic(item), 50);
}
else
{
// this code is the default ASP.NET implementation of Menu_HoverStatic
var node = Menu_HoverRoot(item);
var data = Menu_GetData(item);
if (!data) return;
__disappearAfter = data.disappearAfter;
Menu_Expand(node, data.horizontalOffset, data.verticalOffset);
}
}
function delayMenu_HoverStatic(item)
{
return (function()
{
overrideMenu_HoverStatic(item);
});
}
//]]>
</script>
</form>
  <!-- Google Code -->
  <script type="text/javascript">
  var _gaq = _gaq || [];
  _gaq.push(['_setAccount', 'UA-16139255-17']);
  _gaq.push(['_setDomainName', '.dsm5.org']);
  _gaq.push(['_trackPageview']);
  (function() {
    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + 
'.google-analytics.com/ga.js';
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
  })();
</script>
</body>
</html>